
Title:
Progesterone
Text:
Sex hormone
.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}This article is about progesterone as a hormone. For its use as a medication, see progesterone (medication).
.mw-parser-output .ib-chembox{border-collapse:collapse;text-align:left}.mw-parser-output .ib-chembox td,.mw-parser-output .ib-chembox th{border:1px solid #a2a9b1}

Progesterone









Names




Preferred IUPAC name
(1S,3aS,3bS,9aR,9bS,11aS)-1-Acetyl-9a,11a-dimethyl-1,2,3,3a,3b,4,5,8,9,9a,9b,10,11,11a-tetradecahydro-7H-cyclopenta[a]phenanthren-7-one



Other names
P4;[1] Pregnenedione; Pregn-4-ene-3,20-dione[2][3]


Identifiers



CAS Number

57-83-0 Y


3D model (JSmol)

Interactive image





ChEBI

CHEBI:17026 Y


ChEMBL

ChEMBL103 Y


ChemSpider

5773 Y


DrugBank

DB00396 Y


ECHA InfoCard

100.000.318 






KEGG

C00410 N



PubChem CID

5994



UNII

4G7DS2Q64Y Y



CompTox Dashboard (EPA)

DTXSID3022370 



InChI
InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1 NKey: RJKFOVLPORLFTN-LEKSSAKUSA-N Y




SMILES
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C



Properties


Chemical formula

C21H30O2


Molar mass

314.469 g/mol   





Melting point

126  















log P

4.04[4]





Pharmacology



ATC code

G03DA04 (WHO) 






Routes ofadministration

By mouth, topical/transdermal, vaginal, intramuscular injection, subcutaneous injection, subcutaneous implant


Pharmacokinetics:




Bioavailability

OMP: <10%[5][6]




Protein binding

• Albumin: 80%• CBG: 18%• SHBG: <1%• Free: 1–2%[7][8]




Metabolism

Hepatic (CYP2C19, CYP3A4, CYP2C9, 5α-reductase, 3α-HSD, 17α-hydroxylase, 21-hydroxylase, 20α-HSD)[9][10]






Biological half-life

OMP: 16–18 hours[5][6][11]IM: 22–26 hours[6][12]SC: 13–18 hours[12]





Excretion

Renal








Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).


N verify (what is YN ?)


Infobox references







Chemical compound
Progesterone (P4) is an endogenous steroid and progestogen sex hormone involved in the menstrual cycle, pregnancy, and embryogenesis of humans and other species.[1][13] It belongs to a group of steroid hormones called the progestogens[13] and is the major progestogen in the body. Progesterone has a variety of important functions in the body. It is also a crucial metabolic intermediate in the production of other endogenous steroids, including the sex hormones and the corticosteroids, and plays an important role in brain function as a neurosteroid.[14]
In addition to its role as a natural hormone, progesterone is also used as a medication, such as in combination with estrogen for contraception, to reduce the risk of uterine or cervical cancer, in hormone replacement therapy, and in feminizing hormone therapy.[15] It was first prescribed in 1934.[16]

.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}Contents

1 Biological activity
2 Biological function

2.1 Hormonal interactions
2.2 Reproductive system
2.3 Breasts

2.3.1 Lobuloalveolar development
2.3.2 Ductal development
2.3.3 Breast cancer risk


2.4 Skin health
2.5 Sexuality

2.5.1 Libido
2.5.2 Homosexuality


2.6 Nervous system
2.7 Brain damage

2.7.1 Proposed mechanism


2.8 Addiction
2.9 Societal
2.10 Other effects


3 Biochemistry

3.1 Biosynthesis
3.2 Distribution
3.3 Metabolism
3.4 Levels

3.4.1 Ranges


3.5 Sources

3.5.1 Animal
3.5.2 Plants




4 Medical use
5 Chemistry

5.1 Synthesis

5.1.1 Semisynthesis 1

5.1.1.1 Semisynthesis 2


5.1.2 Total synthesis




6 History

6.1 Veterinary use


7 References
8 External links



Biological activity[edit]
See also: Pharmacodynamics of progesterone § Mechanism of action
Progesterone is the most important progestogen in the body. As a potent agonist of the nuclear progesterone receptor (nPR) (with an affinity of KD = 1 nM) the resulting effects on ribosomal transcription plays a major role in regulation of female reproduction.[13][17][18] In addition, progesterone is an agonist of the more recently discovered membrane progesterone receptors (mPRs),[19] of which the expression has regulation effects in reproduction function (oocyte maturation, labor, and sperm motility) and cancer although additional research is required to further define the roles.[20] It also functions as a ligand of the PGRMC1 (progesterone receptor membrane component 1) which impacts tumor progression, metabolic regulation, and viability control of nerve cells.[21][22][23] Moreover, progesterone is also known to be an antagonist of the sigma σ1 receptor,[24][25] a negative allosteric modulator of nicotinic acetylcholine receptors,[14] and a potent antagonist of the mineralocorticoid receptor (MR).[26] Progesterone prevents MR activation by binding to this receptor with an affinity exceeding even those of aldosterone and glucocorticoids such as cortisol and corticosterone,[26] and produces antimineralocorticoid effects, such as natriuresis, at physiological concentrations.[27] In addition, progesterone binds to and behaves as a partial agonist of the glucocorticoid receptor (GR), albeit with very low potency (EC50 >100-fold less relative to cortisol).[28][29]
Progesterone, through its neurosteroid active metabolites such as 5α-dihydroprogesterone and allopregnanolone, acts indirectly as a positive allosteric modulator of the GABAA receptor.[30]
Progesterone and some of its metabolites, such as 5β-dihydroprogesterone, are agonists of the pregnane X receptor (PXR),[31] albeit weakly so (EC50 >10 μM).[32] In accordance, progesterone induces several hepatic cytochrome P450 enzymes,[33] such as CYP3A4,[34][35] especially during pregnancy when concentrations are much higher than usual.[36] Perimenopausal women have been found to have greater CYP3A4 activity relative to men and postmenopausal women, and it has been inferred that this may be due to the higher progesterone levels present in perimenopausal women.[34]
Progesterone modulates the activity of CatSper (cation channels of sperm) voltage-gated Ca2+ channels. Since eggs release progesterone, sperm may use progesterone as a homing signal to swim toward eggs (chemotaxis). As a result, it has been suggested that substances that block the progesterone binding site on CatSper channels could potentially be used in male contraception.[37][38]

Biological function[edit]
  During the menstrual cycle, levels of estradiol (an estrogen) vary by 200 percent. Levels of progesterone vary by over 1200 percent.[39]
Hormonal interactions[edit]
Progesterone has a number of physiological effects that are amplified in the presence of estrogens. Estrogens through estrogen receptors (ERs) induce or upregulate the expression of the PR.[40] One example of this is in breast tissue, where estrogens allow progesterone to mediate lobuloalveolar development.[41][42][43]
Elevated levels of progesterone potently reduce the sodium-retaining activity of aldosterone, resulting in natriuresis and a reduction in extracellular fluid volume. Progesterone withdrawal, on the other hand, is associated with a temporary increase in sodium retention (reduced natriuresis, with an increase in extracellular fluid volume) due to the compensatory increase in aldosterone production, which combats the blockade of the mineralocorticoid receptor by the previously elevated level of progesterone.[44]

Reproductive system[edit]
  Micrograph showing changes to the endometrium due to progesterone (decidualization) H&E stain.
Progesterone has key effects via non-genomic signalling on human sperm as they migrate through the female tract before fertilization occurs, though the receptor(s) as yet remain unidentified.[45] Detailed characterisation of the events occurring in sperm in response to progesterone has elucidated certain events including intracellular calcium transients and maintained changes,[46] slow calcium oscillations,[47] now thought to possibly regulate motility.[48] It is produced by the ovaries.[49] Progesterone has also been shown to demonstrate effects on octopus spermatozoa.[50]
Progesterone is sometimes called the "hormone of pregnancy",[51] and it has many roles relating to the development of the fetus:

Progesterone converts the endometrium to its secretory stage to prepare the uterus for implantation. At the same time progesterone affects the vaginal epithelium and cervical mucus, making it thick and impenetrable to sperm. Progesterone is anti-mitogenic in endometrial epithelial cells, and as such, mitigates the tropic effects of estrogen.[52] If pregnancy does not occur, progesterone levels will decrease, leading, in the human, to menstruation. Normal menstrual bleeding is progesterone-withdrawal bleeding. If ovulation does not occur and the corpus luteum does not develop, levels of progesterone may be low, leading to anovulatory dysfunctional uterine bleeding.
During implantation and gestation, progesterone appears to decrease the maternal immune response to allow for the acceptance of the pregnancy.[53]
Progesterone decreases contractility of the uterine smooth muscle.[51] This effect contributes to prevention of preterm labor.[53]
A drop in progesterone levels is possibly one step that facilitates the onset of labor.
In addition progesterone inhibits lactation during pregnancy. The fall in progesterone levels following delivery is one of the triggers for milk production.
The fetus metabolizes placental progesterone in the production of adrenal steroids.

Breasts[edit]
See also: Breast development § Biochemistry
Lobuloalveolar development[edit]
Progesterone plays an important role in breast development in women. In conjunction with prolactin, it mediates lobuloalveolar maturation of the mammary glands during pregnancy to allow for milk production and thus lactation and breastfeeding of offspring following parturition (childbirth).[54] Estrogen induces expression of the PR in breast tissue and hence progesterone is dependent on estrogen to mediate lobuloalveolar development.[41][42][43] It has been found that RANKL is a critical downstream mediator of progesterone-induced lobuloalveolar maturation.[55] RANKL knockout mice show an almost identical mammary phenotype to PR knockout mice, including normal mammary ductal development but complete failure of the development of lobuloalveolar structures.[55]

Ductal development[edit]
Though to a far lesser extent than estrogen, which is the major mediator of mammary ductal development (via the ERα),[56][57] progesterone may be involved in ductal development of the mammary glands to some extent as well.[58] PR knockout mice or mice treated with the PR antagonist mifepristone show delayed although otherwise normal mammary ductal development at puberty.[58] In addition, mice modified to have overexpression of PRA display ductal hyperplasia,[55] and progesterone induces ductal growth in the mouse mammary gland.[58] Progesterone mediates ductal development mainly via induction of the expression of amphiregulin, the same growth factor that estrogen primarily induces the expression of to mediate ductal development.[58] These animal findings suggest that, while not essential for full mammary ductal development, progesterone seems to play a potentiating or accelerating role in estrogen-mediated mammary ductal development.[58]

Breast cancer risk[edit]
Progesterone also appears to be involved in the pathophysiology of breast cancer, though its role, and whether it is a promoter or inhibitor of breast cancer risk, has not been fully elucidated.[59] In any case, while most synthetic progestins, like medroxyprogesterone acetate, have been found to increase the risk of breast cancer in postmenopausal women in combination with estrogen as a component of hormone replacement therapy.[60][61] The combination may increase risk due to growth-promoting effects.[62] Whereas the combination of natural progesterone (or the atypical progestin dydrogesterone) with estrogen has not been found to increase breast cancer risk.[60][61]

Skin health[edit]
The estrogen receptor, as well as the progesterone receptor, have been detected in the skin, including in keratinocytes and fibroblasts.[63][64] At menopause and thereafter, decreased levels of female sex hormones result in atrophy, thinning, and increased wrinkling of the skin and a reduction in skin elasticity, firmness, and strength.[63][64] These skin changes constitute an acceleration in skin aging and are the result of decreased collagen content, irregularities in the morphology of epidermal skin cells, decreased ground substance between skin fibers, and reduced capillaries and blood flow.[63][64] The skin also becomes more dry during menopause, which is due to reduced skin hydration and surface lipids (sebum production).[63] Along with chronological aging and photoaging, estrogen deficiency in menopause is one of the three main factors that predominantly influences skin aging.[63]
Hormone replacement therapy, consisting of systemic treatment with estrogen alone or in combination with a progestogen, has well-documented and considerable beneficial effects on the skin of postmenopausal women.[63][64] These benefits include increased skin collagen content, skin thickness and elasticity, and skin hydration and surface lipids.[63][64] Topical estrogen has been found to have similar beneficial effects on the skin.[63] In addition, a study has found that topical 2% progesterone cream significantly increases skin elasticity and firmness and observably decreases wrinkles in peri- and postmenopausal women.[64] Skin hydration and surface lipids, on the other hand, did not significantly change with topical progesterone.[64] These findings suggest that progesterone, like estrogen, also has beneficial effects on the skin, and may be independently protective against skin aging.[64]

Sexuality[edit]
Libido[edit]
See also: Sexual motivation and hormones
Progesterone and its neurosteroid active metabolite allopregnanolone appear to be importantly involved in libido in females.[65]

Homosexuality[edit]
Dr. Diana Fleischman, of the University of Portsmouth, and colleagues looked for a relationship between progesterone and sexual attitudes in 92 women. Their research, published in the Archives of Sexual Behavior found that women who had higher levels of progesterone scored higher on a questionnaire measuring homoerotic motivation. They also found that men who had high levels of progesterone were more likely to have higher homoerotic motivation scores after affiliative priming compared to men with low levels of progesterone.[66][67][68][69]

Nervous system[edit]
Progesterone, like pregnenolone and dehydroepiandrosterone (DHEA), belongs to an important group of endogenous steroids called neurosteroids. It can be metabolized within all parts of the central nervous system.[70]
Neurosteroids are neuromodulators, and are neuroprotective, neurogenic, and regulate neurotransmission and myelination.[71] The effects of progesterone as a neurosteroid are mediated predominantly through its interactions with non-nuclear PRs, namely the mPRs and PGRMC1, as well as certain other receptors, such as the σ1 and nACh receptors.[medical citation needed]

Brain damage[edit]
See also: Progesterone (medication) § Other uses
Previous studies have shown that progesterone supports the normal development of neurons in the brain, and that the hormone has a protective effect on damaged brain tissue. It has been observed in animal models that females have reduced susceptibility to traumatic brain injury and this protective effect has been hypothesized to be caused by increased circulating levels of estrogen and progesterone in females.[72]

Proposed mechanism[edit]
The mechanism of progesterone protective effects may be the reduction of inflammation that follows brain trauma and hemorrhage.[73][74]
Damage incurred by traumatic brain injury is believed to be caused in part by mass depolarization leading to excitotoxicity. One way in which progesterone helps to alleviate some of this excitotoxicity is by blocking the voltage-dependent calcium channels that trigger neurotransmitter release.[75] It does so by manipulating the signaling pathways of transcription factors involved in this release. Another method for reducing the excitotoxicity is by up-regulating the GABAA, a widespread inhibitory neurotransmitter receptor.[76]
Progesterone has also been shown to prevent apoptosis in neurons, a common consequence of brain injury.[77] It does so by inhibiting enzymes involved in the apoptosis pathway specifically concerning the mitochondria, such as activated caspase 3 and cytochrome c.
Not only does progesterone help prevent further damage, it has also been shown to aid in neuroregeneration.[78] One of the serious effects of traumatic brain injury includes edema. Animal studies show that progesterone treatment leads to a decrease in edema levels by increasing the concentration of macrophages and microglia sent to the injured tissue.[75][79] This was observed in the form of reduced leakage from the blood brain barrier in secondary recovery in progesterone treated rats. In addition, progesterone was observed to have antioxidant properties, reducing the concentration of oxygen free radicals faster than without.[76] There is also evidence that the addition of progesterone can also help remyelinate damaged axons due to trauma, restoring some lost neural signal conduction.[76] Another way progesterone aids in regeneration includes increasing the circulation of endothelial progenitor cells in the brain.[80] This helps new vasculature to grow around scar tissue which helps repair the area of insult.

Addiction[edit]
See also: Progesterone (medication) § Addiction
Progesterone enhances the function of serotonin receptors in the brain, so an excess or deficit of progesterone has the potential to result in significant neurochemical issues. This provides an explanation for why some people resort to substances that enhance serotonin activity such as nicotine, alcohol, and cannabis when their progesterone levels fall below optimal levels.[81]

Sex differences in hormone levels may induce women to respond differently than men to nicotine. When women undergo cyclic changes or different hormonal transition phases (menopause, pregnancy, adolescence), there are changes in their progesterone levels.[82] Therefore, females have an increased biological vulnerability to nicotine's reinforcing effects compared to males and progesterone may be used to counter this enhanced vulnerability. This information supports the idea that progesterone can affect behavior.[81]
Similar to nicotine, cocaine also increases the release of dopamine in the brain. The neurotransmitter is involved in the reward center and is one of the main neurotransmitters involved with substance abuse and reliance. In a study of cocaine users, it was reported that progesterone reduced craving and the feeling of being stimulated by cocaine. Thus, progesterone was suggested as an agent that decreases cocaine craving by reducing the dopaminergic properties of the drug.[83]
Societal[edit]
In a 2012 University of Amsterdam study of 120 women, women's luteal phase (higher levels of progesterone, and increasing levels of estrogen) was correlated with lower level of competitive behavior in gambling and math contest scenarios, while their premenstrual phase (sharply-decreasing levels of progesterone, and decreasing levels of estrogen) was correlated with a higher level of competitive behavior.[84]

Other effects[edit]
Progesterone also has a role in skin elasticity and bone strength, in respiration, in nerve tissue and in female sexuality, and the presence of progesterone receptors in certain muscle and fat tissue may hint at a role in sexually dimorphic proportions of those.[85][infringing link?]
During pregnancy, progesterone is said to decrease uterine irritability.[86]
During pregnancy, progesterone helps to suppress immune responses of the mother to fetal antigens, which prevents rejection of the fetus.[86]
Progesterone raises epidermal growth factor-1 (EGF-1) levels, a factor often used to induce proliferation, and used to sustain cultures, of stem cells.[87]
Progesterone increases core temperature (thermogenic function) during ovulation.[88][89]
Progesterone reduces spasm and relaxes smooth muscle. Bronchi are widened and mucus regulated. (PRs are widely present in submucosal tissue.)
Progesterone acts as an antiinflammatory agent and regulates the immune response.
Progesterone reduces gall-bladder activity.[90]
Progesterone normalizes blood clotting and vascular tone, zinc and copper levels, cell oxygen levels, and use of fat stores for energy.
Progesterone may affect gum health, increasing risk of gingivitis (gum inflammation).[91]
Progesterone appears to prevent endometrial cancer (involving the uterine lining) by regulating the effects of estrogen.
Progesterone plays an important role in the signaling of insulin release and pancreatic function, and may affect the susceptibility to diabetes or gestational diabetes.[92][93]
Biochemistry[edit]
Biosynthesis[edit]
  Steroidogenesis, showing progesterone among the progestogens in yellow area.[94]
In mammals, progesterone, like all other steroid hormones, is synthesized from pregnenolone, which itself is derived from cholesterol.
Cholesterol undergoes double oxidation to produce 22R-hydroxycholesterol and then 20α,22R-dihydroxycholesterol. This vicinal diol is then further oxidized with loss of the side chain starting at position C22 to produce pregnenolone. This reaction is catalyzed by cytochrome P450scc.
The conversion of pregnenolone to progesterone takes place in two steps. First, the 3β-hydroxyl group is oxidized to a keto group and second, the double bond is moved to C4, from C5 through a keto/enol tautomerization reaction.[95] This reaction is catalyzed by 3β-hydroxysteroid dehydrogenase/δ5-4-isomerase.
Progesterone in turn is the precursor of the mineralocorticoid aldosterone, and after conversion to 17α-hydroxyprogesterone, of cortisol and androstenedione. Androstenedione can be converted to testosterone, estrone, and estradiol, highlighting the critical role of progesterone in testosterone synthesis.
Pregnenolone and progesterone can also be synthesized by yeast.[96]
Approximately 25 mg of progesterone is secreted from the ovaries per day in women, while the adrenal glands produce about 2 mg of progesterone per day.[97]


.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}vte Production rates, secretion rates, clearance rates, and blood levels of major sex hormones


Sex

Sex hormone

Reproductivephase

Bloodproduction rate

Gonadalsecretion rate

Metabolicclearance rate

Reference range (serum levels)


SI units

Non-SI units


Men

Androstenedione

–

2.8 mg/day

1.6 mg/day

2200 L/day

2.8–7.3 nmol/L

80–210 ng/dL


Testosterone

–

6.5 mg/day

6.2 mg/day

950 L/day

6.9–34.7 nmol/L

200–1000 ng/dL


Estrone

–

150 μg/day

110 μg/day

2050 L/day

37–250 pmol/L

10–70 pg/mL


Estradiol

–

60 μg/day

50 μg/day

1600 L/day

<37–210 pmol/L

10–57 pg/mL


Estrone sulfate

–

80 μg/day

Insignificant

167 L/day

600–2500 pmol/L

200–900 pg/mL


Women

Androstenedione

–

3.2 mg/day

2.8 mg/day

2000 L/day

3.1–12.2 nmol/L

89–350 ng/dL


Testosterone

–

190 μg/day

60 μg/day

500 L/day

0.7–2.8 nmol/L

20–81 ng/dL


Estrone

Follicular phase

110 μg/day

80 μg/day

2200 L/day

110–400 pmol/L

30–110 pg/mL


Luteal phase

260 μg/day

150 μg/day

2200 L/day

310–660 pmol/L

80–180 pg/mL


Postmenopause

40 μg/day

Insignificant

1610 L/day

22–230 pmol/L

6–60 pg/mL


Estradiol

Follicular phase

90 μg/day

80 μg/day

1200 L/day

<37–360 pmol/L

10–98 pg/mL


Luteal phase

250 μg/day

240 μg/day

1200 L/day

699–1250 pmol/L

190–341 pg/mL


Postmenopause

6 μg/day

Insignificant

910 L/day

<37–140 pmol/L

10–38 pg/mL


Estrone sulfate

Follicular phase

100 μg/day

Insignificant

146 L/day

700–3600 pmol/L

250–1300 pg/mL


Luteal phase

180 μg/day

Insignificant

146 L/day

1100–7300 pmol/L

400–2600 pg/mL


Progesterone

Follicular phase

2 mg/day

1.7 mg/day

2100 L/day

0.3–3 nmol/L

0.1–0.9 ng/mL


Luteal phase

25 mg/day

24 mg/day

2100 L/day

19–45 nmol/L

6–14 ng/mL


Notes and sources
Notes: "The concentration of a steroid in the circulation is determined by the rate at which it is secreted from glands, the rate of metabolism of precursor or prehormones into the steroid, and the rate at which it is extracted by tissues and metabolized. The secretion rate of a steroid refers to the total secretion of the compound from a gland per unit time. Secretion rates have been assessed by sampling the venous effluent from a gland over time and subtracting out the arterial and peripheral venous hormone concentration. The metabolic clearance rate of a steroid is defined as the volume of blood that has been completely cleared of the hormone per unit time. The production rate of a steroid hormone refers to entry into the blood of the compound from all possible sources, including secretion from glands and conversion of prohormones into the steroid of interest. At steady state, the amount of hormone entering the blood from all sources will be equal to the rate at which it is being cleared (metabolic clearance rate) multiplied by blood concentration (production rate = metabolic clearance rate × concentration). If there is little contribution of prohormone metabolism to the circulating pool of steroid, then the production rate will approximate the secretion rate." Sources: See template.

Distribution[edit]
Progesterone binds extensively to plasma proteins, including albumin (50–54%) and transcortin (43–48%).[98] It has similar affinity for albumin relative to the PR.[17]

Metabolism[edit]
The metabolism of progesterone is rapid and extensive and occurs mainly in the liver,[99][100][101] though enzymes that metabolize progesterone are also expressed widely in the brain, skin, and various other extrahepatic tissues.[70][102] Progesterone has an elimination half-life of only approximately 5 minutes in circulation.[99] The metabolism of progesterone is complex, and it may form as many as 35 different unconjugated metabolites when it is ingested orally.[101][103] Progesterone is highly susceptible to enzymatic reduction via reductases and hydroxysteroid dehydrogenases due to its double bond (between the C4 and C5 positions) and its two ketones (at the C3 and C20 positions).[101]
The major metabolic pathway of progesterone is reduction by 5α-reductase[70] and 5β-reductase into the dihydrogenated 5α-dihydroprogesterone and 5β-dihydroprogesterone, respectively.[100][101][104][105] This is followed by the further reduction of these metabolites via 3α-hydroxysteroid dehydrogenase and 3β-hydroxysteroid dehydrogenase into the tetrahydrogenated allopregnanolone, pregnanolone, isopregnanolone, and epipregnanolone.[106][100][101][104] Subsequently, 20α-hydroxysteroid dehydrogenase and 20β-hydroxysteroid dehydrogenase reduce these metabolites to form the corresponding hexahydrogenated pregnanediols (eight different isomers in total),[100][105] which are then conjugated via glucuronidation and/or sulfation, released from the liver into circulation, and excreted by the kidneys into the urine.[99][101] The major metabolite of progesterone in the urine is the 3α,5β,20α isomer of pregnanediol glucuronide, which has been found to constitute 15 to 30% of an injection of progesterone.[17][107] Other metabolites of progesterone formed by the enzymes in this pathway include 3α-dihydroprogesterone, 3β-dihydroprogesterone, 20α-dihydroprogesterone, and 20β-dihydroprogesterone, as well as various combination products of the enzymes aside from those already mentioned.[17][101][107][108] Progesterone can also first be hydroxylated (see below) and then reduced.[101] Endogenous progesterone is metabolized approximately 50% into 5α-dihydroprogesterone in the corpus luteum, 35% into 3β-dihydroprogesterone in the liver, and 10% into 20α-dihydroprogesterone.[109]
Relatively small portions of progesterone are hydroxylated via 17α-hydroxylase (CYP17A1) and 21-hydroxylase (CYP21A2) into 17α-hydroxyprogesterone and 11-deoxycorticosterone (21-hydroxyprogesterone), respectively,[103] and pregnanetriols are formed secondarily to 17α-hydroxylation.[110][111] Even smaller amounts of progesterone may be also hydroxylated via 11β-hydroxylase (CYP11B1) and to a lesser extent via aldosterone synthase (CYP11B2) into 11β-hydroxyprogesterone.[112][113] In addition, progesterone can be hydroxylated in the liver by other cytochrome P450 enzymes which are not steroid-specific.[114] 6β-Hydroxylation, which is catalyzed mainly by CYP3A4, is the major transformation, and is responsible for approximately 70% of cytochrome P450-mediated progesterone metabolism.[114] Other routes include 6α-, 16α-, and 16β-hydroxylation.[101] However, treatment of women with ketoconazole, a strong CYP3A4 inhibitor, had minimal effects on progesterone levels, producing only a slight and non-significant increase, and this suggests that cytochrome P450 enzymes play only a small role in progesterone metabolism.[115]






vte Metabolism of progesterone in humans[116]

 
 

Progesterone
17α-Hydroxyprogesterone
11-Deoxycorticosterone
Pregnanetriols(8 isomers)
5α-Dihydroprogesterone
5β-Dihydroprogesterone
Allopregnanolone
Isopregnanolone
Pregnanolone
Epipregnanolone
Pregnanediols(8 isomers)
17α-Hydroxylase
21-Hydroxylase
Multiple
5α-Reductase
5β-Reductase
3α-HSD
3β-HSD
3α-HSD
3β-HSD
20α-HSD
20β-HSD


This diagram illustrates the metabolic pathways involved in the metabolism of progesterone in humans. In addition to the transformations shown in the diagram, conjugation, specifically glucuronidation and sulfation, occurs with metabolites of progesterone that have one or more available hydroxyl (–OH) groups.



Levels[edit]
  Progesterone levels across the menstrual cycle in normally cycling and ovulatory women.[117] The horizontal lines are the mean integrated levels for each curve. The vertical line is mid-cycle.
In women, progesterone levels are relatively low during the preovulatory phase of the menstrual cycle, rise after ovulation, and are elevated during the luteal phase, as shown in the diagram above. Progesterone levels tend to be less than 2 ng/mL prior to ovulation and greater than 5 ng/mL after ovulation. If pregnancy occurs, human chorionic gonadotropin is released, maintaining the corpus luteum and allowing it to maintain levels of progesterone. Between 7 and 9 weeks, the placenta begins to produce progesterone in place of the corpus luteum in a process called the luteal-placental shift.[118]
After the luteal-placental shift, progesterone levels start to rise further and may reach 100 to 200 ng/mL at term. Whether a decrease in progesterone levels is critical for the initiation of labor has been argued and may be species-specific. After delivery of the placenta and during lactation, progesterone levels are very low.
Progesterone levels are low in children and postmenopausal women.[119] Adult males have levels similar to those in women during the follicular phase of the menstrual cycle.

Ranges[edit]
Blood test results should always be interpreted using the reference ranges provided by the laboratory that performed the results. Example reference ranges are listed below.



Person type
Reference range for blood test


Lower limit
Upper limit
Unit


Female - menstrual cycle
(see diagram below)


Female - postmenopausal
<0.2[120]
1[120]
ng/mL


<0.6[121]
3[121]
nmol/L


Female on oral contraceptives
0.34[120]
0.92[120]
ng/mL


1.1[121]
2.9[121]
nmol/L


Males ≥16 years
0.27[120]
0.9[120]
ng/mL


0.86[121]
2.9[121]
nmol/L


Female or male 1–9 years
0.1[120]
4.1[120] or 4.5[120]
ng/mL


0.3[121]
13[121]
nmol/L

Reference ranges for the blood content of progesterone during the menstrual cycle
  Progesterone levels during the menstrual cycle.[122] • The ranges denoted By biological stage may be used in closely monitored menstrual cycles in regard to other markers of its biological progression, with the time scale being compressed or stretched to how much faster or slower, respectively, the cycle progresses compared to an average cycle. • The ranges denoted Inter-cycle variability are more appropriate to use in non-monitored cycles with only the beginning of menstruation known, but where the woman accurately knows her average cycle lengths and time of ovulation, and that they are somewhat averagely regular, with the time scale being compressed or stretched to how much a woman's average cycle length is shorter or longer, respectively, than the average of the population. • The ranges denoted Inter-woman variability are more appropriate to use when the average cycle lengths and time of ovulation are unknown, but only the beginning of menstruation is given.

Sources[edit]
Animal[edit]
Progesterone is produced in high amounts in the ovaries (by the corpus luteum) from the onset of puberty to menopause, and is also produced in smaller amounts by the adrenal glands after the onset of adrenarche in both males and females. To a lesser extent, progesterone is produced in nervous tissue, especially in the brain, and in adipose (fat) tissue, as well.
During human pregnancy, progesterone is produced in increasingly high amounts by the ovaries and placenta. At first, the source is the corpus luteum that has been "rescued" by the presence of human chorionic gonadotropin (hCG) from the conceptus. However, after the 8th week, production of progesterone shifts to the placenta. The placenta utilizes maternal cholesterol as the initial substrate, and most of the produced progesterone enters the maternal circulation, but some is picked up by the fetal circulation and used as substrate for fetal corticosteroids. At term the placenta produces about 250 mg progesterone per day.
An additional animal source of progesterone is milk products. After consumption of milk products the level of bioavailable progesterone goes up.[123]

Plants[edit]
In at least one plant, Juglans regia, progesterone has been detected.[124] In addition, progesterone-like steroids are found in Dioscorea mexicana. Dioscorea mexicana is a plant that is part of the yam family native to Mexico.[125] It contains a steroid called diosgenin that is taken from the plant and is converted into progesterone.[126] Diosgenin and progesterone are also found in other Dioscorea species, as well as in other plants that are not closely related, such as fenugreek.
Another plant that contains substances readily convertible to progesterone is Dioscorea pseudojaponica native to Taiwan. Research has shown that the Taiwanese yam contains saponins — steroids that can be converted to diosgenin and thence to progesterone.[127]
Many other Dioscorea species of the yam family contain steroidal substances from which progesterone can be produced. Among the more notable of these are Dioscorea villosa and Dioscorea polygonoides. One study showed that the Dioscorea villosa contains 3.5% diosgenin.[128] Dioscorea polygonoides has been found to contain 2.64% diosgenin as shown by gas chromatography-mass spectrometry.[129] Many of the Dioscorea species that originate from the yam family grow in countries that have tropical and subtropical climates.[130]

Medical use[edit]
Main articles: Progesterone (medication), Pharmacodynamics of progesterone, and Pharmacokinetics of progesterone
Progesterone is used as a medication. It is used in combination with estrogens mainly in hormone therapy for menopausal symptoms and low sex hormone levels in women.[103][131] It is also used in women to support pregnancy and fertility and to treat gynecological disorders.[132][133][134][135] Progesterone has been shown to  prevent miscarriage in women with 1) vaginal bleeding early in their current pregnancy and 2) a previous history of miscarriage.[136] Progesterone can be taken by mouth, through the vagina, and by injection into muscle or fat, among other routes.[103]

Chemistry[edit]
  A sample of progesterone.
See also: List of neurosteroids
Progesterone is a naturally occurring pregnane steroid and is also known as pregn-4-ene-3,20-dione.[137][138] It has a double bond (4-ene) between the C4 and C5 positions and two ketone groups (3,20-dione), one at the C3 position and the other at the C20 position.[137][138]

Synthesis[edit]
Semisynthesis 1[edit]
An economical semisynthesis of progesterone from the plant steroid diosgenin isolated from yams was developed by Russell Marker in 1940 for the Parke-Davis pharmaceutical company.[139] This synthesis is known as the Marker degradation. Additional semisyntheses of progesterone have also been reported starting from a variety of steroids. For the example, cortisone can be simultaneously deoxygenated at the C-17 and C-21 position by treatment with iodotrimethylsilane in chloroform to produce 11-keto-progesterone (ketogestin), which in turn can be reduced at position-11 to yield progesterone.[140]

  The Marker semisynthesis of progesterone from diosgenin.[139]

Semisynthesis 2[edit]
Progesterone can also be made from the stigmasterol found in soybean oil also. c.f. Percy Julian.

  Stigmasterol to progesterone synthesis.[141][142][143][144][145]

Total synthesis[edit]
  The Johnson total synthesis of progesterone.[146]
A total synthesis of progesterone was reported in 1971 by W.S. Johnson.[146] The synthesis begins with reacting the phosphonium salt 7 with phenyl lithium to produce the phosphonium ylide 8. The ylide 8 is reacted with an aldehyde to produce the alkene 9. The ketal protecting groups of 9 are hydrolyzed to produce the diketone 10, which in turn is cyclized to form the cyclopentenone 11. The ketone of 11 is reacted with methyl lithium to yield the tertiary alcohol 12, which in turn is treated with acid to produce the tertiary cation 13. The key step of the synthesis is the π-cation cyclization of 13 in which the B-, C-, and D-rings of the steroid are simultaneously formed to produce 14. This step resembles the cationic cyclization reaction used in the biosynthesis of steroids and hence is referred to as biomimetic. In the next step the enol orthoester is hydrolyzed to produce the ketone 15. The cyclopentene A-ring is then opened by oxidizing with ozone to produce 16. Finally, the diketone 17 undergoes an intramolecular aldol condensation by treating with aqueous potassium hydroxide to produce progesterone.[146]

History[edit]
George W. Corner and Willard M. Allen discovered the hormonal action of progesterone in 1929.[17][147][148][149] By 1931–1932, nearly pure crystalline material of high progestational activity had been isolated from the corpus luteum of animals, and by 1934, pure crystalline progesterone had been refined and obtained and the chemical structure of progesterone was determined.[17][148] This was achieved by Adolf Butenandt at the Chemisches Institut of Technical University in Danzig, who extracted this new compound from several thousand liters of urine.[150]
Chemical synthesis of progesterone from stigmasterol and pregnanediol was accomplished later that year.[148][151] Up to this point, progesterone, known generically as corpus luteum hormone, had been being referred to by several groups by different names, including corporin, lutein, luteosterone, and progestin.[17][152] In 1935, at the time of the Second International Conference on the Standardization of Sex Hormones in London, England, a compromise was made between the groups and the name progesterone (progestational steroidal ketone) was created.[17][153]


Veterinary use[edit]
The use of progesterone in tests dog breeding to pinpoint ovulation is becoming more widely used.  There are several tests available but the most reliable test is a blood test with blood drawn by a veterinarian and sent to a lab for processing.  Results can usually be obtained with 24 to 72 hours.  The rationale for using progesterone tests is that increased numbers begin in close proximity to preovulatory surge in gonadotrophins and continue through ovulation and estrus.  When progesterone levels reach certain levels they can signal the stage of estrus the female is.  Prediction of birth date of the pending litter can be very accurate if ovulation date is known.  Puppies deliver with a day or two of 9 weeks gestation in most cases.  It is not possible to determine pregnancy using progesterone tests once a breeding has taken place, however.  This is due to the fact that, in dogs, progestrone levels remain elevated throughout the estrus period.[154]

References[edit]
.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}

^ a b .mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}Jameson JL, De Groot LJ (25 February 2015). Endocrinology: Adult and Pediatric E-Book. Elsevier Health Sciences. p. 2179. ISBN 978-0-323-32195-2.

^ Adler N, Pfaff D, Goy RW (6 Dec 2012). Handbook of Behavioral Neurobiology Volume 7 Reproduction (1st ed.). New York: Plenum Press. p. 189. ISBN 978-1-4684-4834-4. Retrieved 4 July 2015.

^ "progesterone (CHEBI:17026)". ChEBI. European Molecular Biology Laboratory-EBI. Retrieved 4 July 2015.

^ "Progesterone_msds".

^ a b Stanczyk FZ (September 2002). "Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception". Reviews in Endocrine & Metabolic Disorders. 3 (3): 211–24. doi:10.1023/A:1020072325818. PMID 12215716. S2CID 27018468.

^ a b c Simon JA, Robinson DE, Andrews MC, Hildebrand JR, Rocci ML, Blake RE, Hodgen GD (July 1993). "The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone". Fertility and Sterility. 60 (1): 26–33. doi:10.1016/S0015-0282(16)56031-2. PMID 8513955.

^ Fritz MA, Speroff L (28 March 2012). Clinical Gynecologic Endocrinology and Infertility. Lippincott Williams & Wilkins. pp. 44–. ISBN 978-1-4511-4847-3.

^ Marshall WJ, Bangert SK (2008). Clinical Chemistry. Elsevier Health Sciences. pp. 192–. ISBN 978-0-7234-3455-9.

^ Yamazaki H, Shimada T (October 1997). "Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes". Archives of Biochemistry and Biophysics. 346 (1): 161–9. doi:10.1006/abbi.1997.0302. PMID 9328296.

^ McKay GA, Walters MR (6 February 2013). Lecture Notes: Clinical Pharmacology and Therapeutics. John Wiley & Sons. p. 33. ISBN 978-1-118-34489-7.

^ Zutshi (1 January 2005). Hormones in Obstetrics and Gynaecology. Jaypee Brothers Publishers. p. 74. ISBN 978-81-8061-427-9.

^ a b Cometti B (November 2015). "Pharmaceutical and clinical development of a novel progesterone formulation". Acta Obstetricia et Gynecologica Scandinavica. 94 (Suppl 161): 28–37. doi:10.1111/aogs.12765. PMID 26342177. S2CID 31974637.

^ a b c King TL, Brucker MC (25 October 2010). Pharmacology for Women's Health. Jones & Bartlett Publishers. pp. 372–373. ISBN 978-1-4496-5800-7.

^ a b Baulieu E, Schumacher M (2000). "Progesterone as a neuroactive neurosteroid, with special reference to the effect of progesterone on myelination". Steroids. 65 (10–11): 605–12. doi:10.1016/s0039-128x(00)00173-2. PMID 11108866. S2CID 14952168.

^ Prior JC (2019). "Progesterone Is Important for Transgender Women's Therapy — Applying Evidence for the Benefits of Progesterone in Ciswomen". The Journal of Clinical Endocrinology & Metabolism. 104 (4): 1181–1186. doi:10.1210/jc.2018-01777. PMID 30608551. S2CID 58620122. Evidence has accrued that normal progesterone (and ovulation), as well as physiological estradiol levels, is necessary during ciswomen’s premenopausal menstrual cycles for current fertility and long-term health; transgender women may require progesterone therapy and similar potential physiological benefits

^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 47X. ISBN 9783527607495.

^ a b c d e f g h Josimovich JB (11 November 2013). Gynecologic Endocrinology. Springer Science & Business Media. pp. 9, 25–29. ISBN 978-1-4613-2157-6.

^ Taraborrelli S (November 2015). "Physiology, production and action of progesterone". Acta Obstetricia et Gynecologica Scandinavica. 94 Suppl 161: 8–16. doi:10.1111/aogs.12771. PMID 26358238. S2CID 40213725.

^ Thomas P, Pang Y (2012). "Membrane progesterone receptors: evidence for neuroprotective, neurosteroid signaling and neuroendocrine functions in neuronal cells". Neuroendocrinology. 96 (2): 162–71. doi:10.1159/000339822. PMC 3489003. PMID 22687885.

^ Valadez-Cosmes P, Vázquez-Martínez ER, Cerbón M, Camacho-Arroyo I (October 2016). "Membrane progesterone receptors in reproduction and cancer". Molecular and Cellular Endocrinology. 434: 166–75. doi:10.1016/j.mce.2016.06.027. PMID 27368976. S2CID 3826650.

^ Meyer C, Schmid R, Schmieding K, Falkenstein E, Wehling M (February 1998). "Characterization of high affinity progesterone-binding membrane proteins by anti-peptide antiserum". Steroids. 63 (2): 111–6. doi:10.1016/s0039-128x(97)00143-8. PMID 9516722. S2CID 40096058.

^ Kabe Y, Handa H, Suematsu M (July 2018). "Function and structural regulation of the carbon monoxide (CO)-responsive membrane protein PGRMC1". Journal of Clinical Biochemistry and Nutrition. 63 (1): 12–17. doi:10.3164/jcbn.17-132. PMC 6064819. PMID 30087538.

^ Ryu CS, Klein K, Zanger UM (2017-03-27). "Membrane Associated Progesterone Receptors: Promiscuous Proteins with Pleiotropic Functions - Focus on Interactions with Cytochromes P450". Frontiers in Pharmacology. 8: 159. doi:10.3389/fphar.2017.00159. PMC 5366339. PMID 28396637.

^ Maurice T, Urani A, Phan VL, Romieu P (November 2001). "The interaction between neuroactive steroids and the sigma1 receptor function: behavioral consequences and therapeutic opportunities". Brain Research. Brain Research Reviews. 37 (1–3): 116–32. doi:10.1016/s0165-0173(01)00112-6. PMID 11744080. S2CID 44931783.

^ Johannessen M, Fontanilla D, Mavlyutov T, Ruoho AE, Jackson MB (February 2011). "Antagonist action of progesterone at σ-receptors in the modulation of voltage-gated sodium channels". American Journal of Physiology. Cell Physiology. 300 (2): C328-37. doi:10.1152/ajpcell.00383.2010. PMC 3043630. PMID 21084640.

^ a b Rupprecht R, Reul JM, van Steensel B, Spengler D, Söder M, Berning B,  et al. (October 1993). "Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands". European Journal of Pharmacology. 247 (2): 145–54. doi:10.1016/0922-4106(93)90072-H. PMID 8282004.

^ Elger W, Beier S, Pollow K, Garfield R, Shi SQ, Hillisch A (November 2003). "Conception and pharmacodynamic profile of drospirenone". Steroids. 68 (10–13): 891–905. doi:10.1016/j.steroids.2003.08.008. PMID 14667981. S2CID 41756726.

^ Attardi BJ, Zeleznik A, Simhan H, Chiao JP, Mattison DR, Caritis SN (December 2007). "Comparison of progesterone and glucocorticoid receptor binding and stimulation of gene expression by progesterone, 17-alpha hydroxyprogesterone caproate, and related progestins". American Journal of Obstetrics and Gynecology. 197 (6): 599.e1–7. doi:10.1016/j.ajog.2007.05.024. PMC 2278032. PMID 18060946.

^ Lei K, Chen L, Georgiou EX, Sooranna SR, Khanjani S, Brosens JJ,  et al. (2012). "Progesterone acts via the nuclear glucocorticoid receptor to suppress IL-1β-induced COX-2 expression in human term myometrial cells". PLOS ONE. 7 (11): e50167. Bibcode:2012PLoSO...750167L. doi:10.1371/journal.pone.0050167. PMC 3509141. PMID 23209664.

^ Paul SM, Purdy RH (March 1992). "Neuroactive steroids". FASEB Journal. 6 (6): 2311–22. doi:10.1096/fasebj.6.6.1347506. PMID 1347506. S2CID 221753076.

^ Kliewer SA, Goodwin B, Willson TM (2002). "The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism". Endocr. Rev. 23 (5): 687–702. doi:10.1210/er.2001-0038. PMID 12372848.

^ Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA (1998). "The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions". J. Clin. Invest. 102 (5): 1016–23. doi:10.1172/JCI3703. PMC 508967. PMID 9727070.

^ Meanwell NA (8 December 2014). Tactics in Contemporary Drug Design. Springer. pp. 161–. ISBN 978-3-642-55041-6.

^ a b Legato MJ, Bilezikian JP (2004). Principles of Gender-specific Medicine. Gulf Professional Publishing. pp. 146–. ISBN 978-0-12-440906-4.

^ Lemke TL, Williams DA (24 January 2012). Foye's Principles of Medicinal Chemistry. Lippincott Williams & Wilkins. p. 164. ISBN 978-1-60913-345-0.

^ Estrogens—Advances in Research and Application: 2013 Edition: ScholarlyBrief. ScholarlyEditions. 21 June 2013. pp. 4–. ISBN 978-1-4816-7550-5.

^ Strünker T, Goodwin N, Brenker C, Kashikar ND, Weyand I, Seifert R, Kaupp UB (March 2011). "The CatSper channel mediates progesterone-induced Ca2+ influx in human sperm". Nature. 471 (7338): 382–6. Bibcode:2011Natur.471..382S. doi:10.1038/nature09769. PMID 21412338. S2CID 4431334. Lay summary – Nature News. {{cite journal}}: Cite uses deprecated parameter |lay-url= (help)

^ Lishko PV, Botchkina IL, Kirichok Y (March 2011). "Progesterone activates the principal Ca2+ channel of human sperm". Nature. 471 (7338): 387–91. Bibcode:2011Natur.471..387L. doi:10.1038/nature09767. PMID 21412339. S2CID 4340309.

^ Prior JC (2020). "Women's reproductive system as balanced estradiol and progesterone actions—A revolutionary, paradigm-shifting concept in women's health". Drug Discovery Today: Disease Models. 32, Part B: 31–40. doi:10.1016/j.ddmod.2020.11.005.

^ Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P (May 1990). "Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B". The EMBO Journal. 9 (5): 1603–14. doi:10.1002/j.1460-2075.1990.tb08280.x. PMC 551856. PMID 2328727.

^ a b Hallam SZ, Osuch JR (1 January 2006). Hormones and Breast Cancer in Post-Menopausal Women. IOS Press. p. 69. ISBN 978-1-58603-653-9.

^ a b Johnson LR (2003). Essential Medical Physiology. Academic Press. p. 770. ISBN 978-0-12-387584-6.

^ a b Coad J, Dunstall M (2011). Anatomy and Physiology for Midwives, with Pageburst online access,3: Anatomy and Physiology for Midwives. Elsevier Health Sciences. p. 413. ISBN 978-0-7020-3489-3.

^ Landau RL, Bergenstal DM, Lugibihl K, Kascht ME (October 1955). "The metabolic effects of progesterone in man". The Journal of Clinical Endocrinology and Metabolism. 15 (10): 1194–215. doi:10.1210/jcem-15-10-1194. PMID 13263410.

^ Correia JN, Conner SJ, Kirkman-Brown JC (May 2007). "Non-genomic steroid actions in human spermatozoa. "Persistent tickling from a laden environment"". Seminars in Reproductive Medicine. 25 (3): 208–19. doi:10.1055/s-2007-973433. PMID 17447210.

^ Kirkman-Brown JC, Bray C, Stewart PM, Barratt CL, Publicover SJ (June 2000). "Biphasic elevation of [Ca(2+)](i) in individual human spermatozoa exposed to progesterone". Developmental Biology. 222 (2): 326–35. doi:10.1006/dbio.2000.9729. PMID 10837122.

^ Kirkman-Brown JC, Barratt CL, Publicover SJ (March 2004). "Slow calcium oscillations in human spermatozoa". The Biochemical Journal. 378 (Pt 3): 827–32. doi:10.1042/BJ20031368. PMC 1223996. PMID 14606954.

^ Harper CV, Barratt CL, Publicover SJ (October 2004). "Stimulation of human spermatozoa with progesterone gradients to simulate approach to the oocyte. Induction of [Ca(2+)](i) oscillations and cyclical transitions in flagellar beating". The Journal of Biological Chemistry. 279 (44): 46315–25. doi:10.1074/jbc.M401194200. PMID 15322137.

^ Marieb, Elaine (2013). Anatomy & physiology. Benjamin-Cummings. p. 903. ISBN 9780321887603.

^ Tosti E, Di Cosmo A, Cuomo A, Di Cristo C, Gragnaniello G (May 2001). "Progesterone induces activation in Octopus vulgaris spermatozoa". Molecular Reproduction and Development. 59 (1): 97–105. doi:10.1002/mrd.1011. PMID 11335951. S2CID 28390608.

^ a b Bowen R (2000-08-06). "Placental Hormones". Retrieved 2008-03-12.

^ Patel B, Elguero S, Thakore S, Dahoud W, Bedaiwy M, Mesiano S (2014). "Role of nuclear progesterone receptor isoforms in uterine pathophysiology". Human Reproduction Update. 21 (2): 155–73. doi:10.1093/humupd/dmu056. PMC 4366574. PMID 25406186.

^ a b Di Renzo GC, Giardina I, Clerici G, Brillo E, Gerli S (July 2016). "Progesterone in normal and pathological pregnancy". Hormone Molecular Biology and Clinical Investigation. 27 (1): 35–48. doi:10.1515/hmbci-2016-0038. PMID 27662646. S2CID 32239449.

^ Macias H, Hinck L (2012). "Mammary gland development". Wiley Interdisciplinary Reviews: Developmental Biology. 1 (4): 533–57. doi:10.1002/wdev.35. PMC 3404495. PMID 22844349.

^ a b c Hilton HN, Graham JD, Clarke CL (September 2015). "Minireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios?". Molecular Endocrinology. 29 (9): 1230–42. doi:10.1210/me.2015-1152. PMC 5414684. PMID 26266959.

^ Strauss JF, Barbieri RL (13 September 2013). Yen and Jaffe's Reproductive Endocrinology. Elsevier Health Sciences. pp. 236–. ISBN 978-1-4557-2758-2.

^ Scaling AL, Prossnitz ER, Hathaway HJ (June 2014). "GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast". Hormones & Cancer. 5 (3): 146–160. doi:10.1007/s12672-014-0174-1. PMC 4091989. PMID 24718936.

^ a b c d e Aupperlee MD, Leipprandt JR, Bennett JM, Schwartz RC, Haslam SZ (May 2013). "Amphiregulin mediates progesterone-induced mammary ductal development during puberty". Breast Cancer Research. 15 (3): R44. doi:10.1186/bcr3431. PMC 3738150. PMID 23705924.

^ Kuhl H, Schneider HP (August 2013). "Progesterone--promoter or inhibitor of breast cancer". Climacteric. 16 Suppl 1: 54–68. doi:10.3109/13697137.2013.768806. PMID 23336704. S2CID 20808536.

^ a b Fournier A, Berrino F, Clavel-Chapelon F (January 2008). "Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study". Breast Cancer Research and Treatment. 107 (1): 103–11. doi:10.1007/s10549-007-9523-x. PMC 2211383. PMID 17333341.

^ a b Campagnoli C, Clavel-Chapelon F, Kaaks R, Peris C, Berrino F (July 2005). "Progestins and progesterone in hormone replacement therapy and the risk of breast cancer". The Journal of Steroid Biochemistry and Molecular Biology. 96 (2): 95–108. doi:10.1016/j.jsbmb.2005.02.014. PMC 1974841. PMID 15908197.

^ Asi N, Mohammed K, Haydour Q, Gionfriddo MR, Vargas OL, Prokop LJ,  et al. (July 2016). "Progesterone vs. synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis". Systematic Reviews. 5 (1): 121. doi:10.1186/s13643-016-0294-5. PMC 4960754. PMID 27456847.

^ a b c d e f g h Raine-Fenning NJ, Brincat MP, Muscat-Baron Y (2003). "Skin aging and menopause : implications for treatment". American Journal of Clinical Dermatology. 4 (6): 371–8. doi:10.2165/00128071-200304060-00001. PMID 12762829. S2CID 20392538.

^ a b c d e f g h Holzer G, Riegler E, Hönigsmann H, Farokhnia S, Schmidt JB, Schmidt B (September 2005). "Effects and side-effects of 2% progesterone cream on the skin of peri- and postmenopausal women: results from a double-blind, vehicle-controlled, randomized study". The British Journal of Dermatology. 153 (3): 626–34. doi:10.1111/j.1365-2133.2005.06685.x. PMID 16120154. S2CID 6077829.

^ King SR (9 November 2012). Neurosteroids and the Nervous System. Springer Science & Business Media. pp. 44–46. ISBN 978-1-4614-5559-2.

^ Fleischman DS, Fessler DM, Cholakians AE (July 2015). "Testing the Affiliation Hypothesis of Homoerotic Motivation in Humans: The Effects of Progesterone and Priming". Archives of Sexual Behavior. 44 (5): 1395–404. doi:10.1007/s10508-014-0436-6. PMID 25420899. S2CID 9864224.

^ "Homosexuality may help us bond | UoP News".

^ Having homosexual thoughts 'is an essential part of human evolution' study suggests The Telegraph

^ Homosexuality May Have Evolved In Humans Because It Helps Us Bond, Scientists Say Huff Post

^ a b c Hanukoglu I, Karavolas HJ, Goy RW (April 1977). "Progesterone metabolism in the pineal, brain stem, thalamus and corpus callosum of the female rat". Brain Research. 125 (2): 313–24. doi:10.1016/0006-8993(77)90624-2. PMID 558037. S2CID 35814845.

^ Schumacher M, Guennoun R, Robert F, Carelli C, Gago N, Ghoumari A, Gonzalez Deniselle MC, Gonzalez SL, Ibanez C, Labombarda F, Coirini H, Baulieu EE, De Nicola AF (June 2004). "Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination". Growth Hormone & IGF Research. 14 Suppl A: S18-33. doi:10.1016/j.ghir.2004.03.007. PMID 15135772.

^ Roof RL, Hall ED (May 2000). "Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone". Journal of Neurotrauma. 17 (5): 367–88. doi:10.1089/neu.2000.17.367. PMID 10833057.

^ Pan DS, Liu WG, Yang XF, Cao F (October 2007). "Inhibitory effect of progesterone on inflammatory factors after experimental traumatic brain injury". Biomedical and Environmental Sciences. 20 (5): 432–8. PMID 18188998.

^ Jiang C, Zuo F, Wang Y, Wan J, Yang Z, Lu H, Chen W, Zang W, Yang Q, Wang J (June 2016). "Progesterone exerts neuroprotective effects and improves long-term neurologic outcome after intracerebral hemorrhage in middle-aged mice". Neurobiology of Aging. 42: 13–24. doi:10.1016/j.neurobiolaging.2016.02.029. PMC 4857017. PMID 27143417.

^ a b Luoma JI, Stern CM, Mermelstein PG (August 2012). "Progesterone inhibition of neuronal calcium signaling underlies aspects of progesterone-mediated neuroprotection". The Journal of Steroid Biochemistry and Molecular Biology. 131 (1–2): 30–6. doi:10.1016/j.jsbmb.2011.11.002. PMC 3303940. PMID 22101209.

^ a b c Stein DG (March 2008). "Progesterone exerts neuroprotective effects after brain injury". Brain Research Reviews. 57 (2): 386–97. doi:10.1016/j.brainresrev.2007.06.012. PMC 2699575. PMID 17826842.

^ Espinoza TR, Wright DW (2011). "The role of progesterone in traumatic brain injury". The Journal of Head Trauma Rehabilitation. 26 (6): 497–9. doi:10.1097/HTR.0b013e31823088fa. PMC 6025750. PMID 22088981.

^ Jiang C, Zuo F, Wang Y, Lu H, Yang Q, Wang J (January 2017). "Progesterone Changes VEGF and BDNF Expression and Promotes Neurogenesis After Ischemic Stroke". Mol Neurobiol. 54 (1): 571–581. doi:10.1007/s12035-015-9651-y. PMC 4938789. PMID 26746666.

^ Herson PS, Koerner IP, Hurn PD (May 2009). "Sex, sex steroids, and brain injury". Seminars in Reproductive Medicine. 27 (3): 229–39. doi:10.1055/s-0029-1216276. PMC 2675922. PMID 19401954.

^ Li Z, Wang B, Kan Z, Zhang B, Yang Z, Chen J, Wang D, Wei H, Zhang JN, Jiang R (January 2012). "Progesterone increases circulating endothelial progenitor cells and induces neural regeneration after traumatic brain injury in aged rats". Journal of Neurotrauma. 29 (2): 343–53. doi:10.1089/neu.2011.1807. PMC 3261789. PMID 21534727.

^ a b Lynch WJ, Sofuoglu M (December 2010). "Role of progesterone in nicotine addiction: evidence from initiation to relapse". Experimental and Clinical Psychopharmacology. 18 (6): 451–61. doi:10.1037/a0021265. PMC 3638762. PMID 21186920.

^ Cosgrove KP, Esterlis I, McKee SA, Bois F, Seibyl JP, Mazure CM, Krishnan-Sarin S, Staley JK, Picciotto MR, O'Malley SS (April 2012). "Sex differences in availability of β2*-nicotinic acetylcholine receptors in recently abstinent tobacco smokers". Archives of General Psychiatry. 69 (4): 418–27. doi:10.1001/archgenpsychiatry.2011.1465. PMC 3508698. PMID 22474108.

^ Mello NK, Knudson IM, Kelly M, Fivel PA, Mendelson JH (October 2011). "Effects of progesterone and testosterone on cocaine self-administration and cocaine discrimination by female rhesus monkeys". Neuropsychopharmacology. 36 (11): 2187–99. doi:10.1038/npp.2011.130. PMC 3176575. PMID 21796112.

^ Buser, Thomas (2012-06-01). "The impact of the menstrual cycle and hormonal contraceptives on competitiveness". Journal of Economic Behavior & Organization. Gender Differences in Risk Aversion and Competition. 83 (1): 1–10. doi:10.1016/j.jebo.2011.06.006. ISSN 0167-2681.

^ Sriram, D (2007). Medicinal Chemistry. New Delhi: Dorling Kindersley India Pvt. Ltd. p. 432. ISBN 978-81-317-0031-0.

^ a b Blackburn S (14 April 2014). Maternal, Fetal, & Neonatal Physiology. Elsevier Health Sciences. pp. 92–. ISBN 978-0-323-29296-2.

^ Faivre EJ, Lange CA (January 2007). "Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells". Molecular and Cellular Biology. 27 (2): 466–80. doi:10.1128/MCB.01539-06. PMC 1800800. PMID 17074804.

^ Nosek, Thomas M. "Section 5/5ch9/s5ch9_13". Essentials of Human Physiology. Archived from the original on 2016-03-24.

^ Rothchild, Irving (1969),  Salhanick, Hilton A.; Kipnis, David M.; Wiele, Raymond L. Vande (eds.), "The Physiologic Basis for the Temperature Raising Effect of Progesterone", Metabolic Effects of Gonadal Hormones and Contraceptive Steroids, Boston, MA: Springer US, pp. 668–675, doi:10.1007/978-1-4684-1782-1_49, ISBN 978-1-4684-1782-1, retrieved 2021-03-22

^ Hould FS, Fried GM, Fazekas AG, Tremblay S, Mersereau WA (December 1988). "Progesterone receptors regulate gallbladder motility". The Journal of Surgical Research. 45 (6): 505–12. doi:10.1016/0022-4804(88)90137-0. PMID 3184927.

^ "Hormones and Oral Health". WebMD.

^ Picard F, Wanatabe M, Schoonjans K, Lydon J, O'Malley BW, Auwerx J (November 2002). "Progesterone receptor knockout mice have an improved glucose homeostasis secondary to beta -cell proliferation". Proceedings of the National Academy of Sciences of the United States of America. 99 (24): 15644–8. doi:10.1073/pnas.202612199. PMC 137770. PMID 12438645.

^ Brănişteanu DD, Mathieu C (March 2003). "Progesterone in gestational diabetes mellitus: guilty or not guilty?". Trends in Endocrinology and Metabolism. 14 (2): 54–6. doi:10.1016/S1043-2760(03)00003-1. PMID 12591170. S2CID 38209977.

^ Häggström M, Richfield D (2014). "Diagram of the pathways of human steroidogenesis". WikiJournal of Medicine. 1 (1). doi:10.15347/wjm/2014.005. ISSN 2002-4436.

^ Bewick PM (2002). Medicinal natural products: a biosynthetic approach. New York: Wiley. p. 244. ISBN 0-471-49641-3.

^ Duport C, Spagnoli R, Degryse E, Pompon D (February 1998). "Self-sufficient biosynthesis of pregnenolone and progesterone in engineered yeast". Nature Biotechnology. 16 (2): 186–9. doi:10.1038/nbt0298-186. PMID 9487528. S2CID 852617.

^ Lemke TL, Williams DA (24 January 2012). Foye's Principles of Medicinal Chemistry. Lippincott Williams & Wilkins. pp. 1397–. ISBN 978-1-60913-345-0.

^ Progesterone - Drugs.com, retrieved 2015-08-23

^ a b c Falcone T, Hurd WW (2007). Clinical Reproductive Medicine and Surgery. Elsevier Health Sciences. pp. 22–. ISBN 978-0-323-03309-1.

^ a b c d Cupps PT (20 February 1991). Reproduction in Domestic Animals. Elsevier. pp. 101–. ISBN 978-0-08-057109-6.

^ a b c d e f g h i Stanczyk FZ (November 2003). "All progestins are not created equal". Steroids. 68 (10–13): 879–90. doi:10.1016/j.steroids.2003.08.003. PMID 14667980. S2CID 44601264.

^ Dowd FJ, Johnson B, Mariotti A (3 September 2016). Pharmacology and Therapeutics for Dentistry. Elsevier Health Sciences. pp. 448–. ISBN 978-0-323-44595-5.

^ a b c d Kuhl H (August 2005). "Pharmacology of estrogens and progestogens: influence of different routes of administration". Climacteric. 8 Suppl 1: 3–63. doi:10.1080/13697130500148875. PMID 16112947. S2CID 24616324.

^ a b Plant TM, Zeleznik AJ (15 November 2014). Knobil and Neill's Physiology of Reproduction. Academic Press. pp. 304–. ISBN 978-0-12-397769-4.

^ a b Santoro NF, Neal-Perry G (11 September 2010). Amenorrhea: A Case-Based, Clinical Guide. Springer Science & Business Media. pp. 13–. ISBN 978-1-60327-864-5.

^ Reddy DS (2010). "Neurosteroids: endogenous role in the human brain and therapeutic potentials". Progress in Brain Research. 186: 113–37. doi:10.1016/B978-0-444-53630-3.00008-7. PMC 3139029. PMID 21094889.

^ a b Baulieu E, Kelly PA (30 November 1990). Hormones: From Molecules to Disease. Springer Science & Business Media. pp. 401–. ISBN 978-0-412-02791-8.

^ Beranič N, Gobec S, Rižner TL (2011). "Progestins as inhibitors of the human 20-ketosteroid reductases, AKR1C1 and AKR1C3". Chem. Biol. Interact. 191 (1–3): 227–33. doi:10.1016/j.cbi.2010.12.012. PMID 21182831.

^ Anderson GD, Odegard PS (October 2004). "Pharmacokinetics of estrogen and progesterone in chronic kidney disease". Adv Chronic Kidney Dis. 11 (4): 357–60. doi:10.1053/j.ackd.2004.07.001. PMID 15492972.

^ Greenblatt JM, Brogan K (27 April 2016). Integrative Therapies for Depression: Redefining Models for Assessment, Treatment and Prevention. CRC Press. pp. 201–. ISBN 978-1-4987-0230-0.

^ Graham C (2 December 2012). Reproductive Biology of the Great Apes: Comparative and Biomedical Perspectives. Elsevier. pp. 179–. ISBN 978-0-323-14971-6.

^ Strushkevich, N.; Gilep, A. A.; Shen, L.; Arrowsmith, C. H.; Edwards, A. M.; Usanov, S. A.; Park, H. W. (2013). "Structural Insights into Aldosterone Synthase Substrate Specificity and Targeted Inhibition". Molecular Endocrinology (Baltimore, Md.). 27 (2): 315–324. doi:10.1210/me.2012-1287. PMC 5417327. PMID 23322723.

^ van Rooyen D, Gent R, Barnard L, Swart AC (April 2018). "The in vitro metabolism of 11β-hydroxyprogesterone and 11-ketoprogesterone to 11-ketodihydrotestosterone in the backdoor pathway". The Journal of Steroid Biochemistry and Molecular Biology. 178: 203–212. doi:10.1016/j.jsbmb.2017.12.014. PMID 29277707. S2CID 3700135.

^ a b de Azevedo Piccinato C (2008). Regulation of Steroid Metabolism and the Hepatic Transcriptome by Estradiol and Progesterone. pp. 24–25. ISBN 978-1-109-04632-8.

^ Akalin S (January 1991). "Effects of ketoconazole in hirsute women". Acta Endocrinologica. 124 (1): 19–22. doi:10.1530/acta.0.1240019. PMID 1825737. S2CID 9831739.

^ Aufrère MB, Benson H (June 1976). "Progesterone: an overview and recent advances". Journal of Pharmaceutical Sciences. 65 (6): 783–800. doi:10.1002/jps.2600650602. PMID 945344.

^ Stricker R, Eberhart R, Chevailler MC, Quinn FA, Bischof P, Stricker R (2006). "Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT analyzer". Clin. Chem. Lab. Med. 44 (7): 883–7. doi:10.1515/CCLM.2006.160. PMID 16776638. S2CID 524952.

^ Csapo AI, Pulkkinen MU, Wiest WG (1973). "Effects of lutectomy and progestreone replacement therapy in early pregnancy patients". Am J Obstet Gynecol. 115 (6): 759–65. doi:10.1016/0002-9378(73)90517-6. PMID 4688578.

^ NIH Clinical Center (2004-08-16). "Progesterone Historical Reference Ranges". United States National Institutes of Health. Archived from the original on 2009-01-09. Retrieved 2008-03-12.

^ a b c d e f g h i Progesterone Reference Ranges, Performed at the Clinical Center at the National Institutes of Health, Bethesda MD, 03Feb09

^ a b c d e f g h Converted from mass values using molar mass of 314.46 g/mol

^ Häggström, Mikael (2014). "Reference ranges for estradiol, progesterone, luteinizing hormone and follicle-stimulating hormone during the menstrual cycle". WikiJournal of Medicine. 1 (1). doi:10.15347/wjm/2014.001. ISSN 2002-4436.

^ Goodson III WH, Handagama P, Moore II DH, Dairkee S (2007-12-13). "Milk products are a source of dietary progesterone". 30th Annual San Antonio Breast Cancer Symposium. pp. abstract # 2028. Retrieved 2008-03-12.

^ Pauli GF, Friesen JB, Gödecke T, Farnsworth NR, Glodny B (March 2010). "Occurrence of progesterone and related animal steroids in two higher plants". Journal of Natural Products. 73 (3): 338–45. doi:10.1021/np9007415. PMID 20108949. S2CID 26467578.

^ Applezweig N (May 1969). "Steroids". Chemical Week. 104: 57–72. PMID 12255132.

^ Noguchi E, Fujiwara Y, Matsushita S, Ikeda T, Ono M, Nohara T (September 2006). "Metabolism of tomato steroidal glycosides in humans". Chemical & Pharmaceutical Bulletin. 54 (9): 1312–4. doi:10.1248/cpb.54.1312. PMID 16946542.

^ Yang DJ, Lu TJ, Hwang LS (October 2003). "Isolation and identification of steroidal saponins in Taiwanese yam cultivar (Dioscorea pseudojaponica Yamamoto)". Journal of Agricultural and Food Chemistry. 51 (22): 6438–44. doi:10.1021/jf030390j. PMID 14558759.

^ "Final report of the amended safety assessment of Dioscorea Villosa (Wild Yam) root extract". International Journal of Toxicology. 23 Suppl 2 (2_suppl): 49–54. 2004. doi:10.1080/10915810490499055. PMID 15513824. S2CID 962216.

^ Niño J, Jiménez DA, Mosquera OM, Correa YM (2007). "Diosgenin quantification by HPLC in a Dioscorea polygonoides tuber collection from colombian flora". Journal of the Brazilian Chemical Society. 18 (5): 1073–1076. doi:10.1590/S0103-50532007000500030.

^ Myoda T, Nagai T, Nagashima T (2005). Properties of starches in yam (Dioscorea spp.) tuber. Current Topics in Food Science and Technology. pp. 105–114. ISBN 81-308-0003-9.

^ Wesp LM, Deutsch MB (2017). "Hormonal and Surgical Treatment Options for Transgender Women and Transfeminine Spectrum Persons". Psychiatr. Clin. North Am. 40 (1): 99–111. doi:10.1016/j.psc.2016.10.006. PMID 28159148.

^ Ruan X, Mueck AO (November 2014). "Systemic progesterone therapy--oral, vaginal, injections and even transdermal?". Maturitas. 79 (3): 248–55. doi:10.1016/j.maturitas.2014.07.009. PMID 25113944.

^ Filicori M (2015). "Clinical roles and applications of progesterone in reproductive medicine: an overview". Acta Obstet Gynecol Scand. 94 Suppl 161: 3–7. doi:10.1111/aogs.12791. PMID 26443945.

^ Ciampaglia W, Cognigni GE (2015). "Clinical use of progesterone in infertility and assisted reproduction". Acta Obstet Gynecol Scand. 94 Suppl 161: 17–27. doi:10.1111/aogs.12770. PMID 26345161. S2CID 40753277.

^ Choi SJ (2017). "Use of progesterone supplement therapy for prevention of preterm birth: review of literatures". Obstet Gynecol Sci. 60 (5): 405–420. doi:10.5468/ogs.2017.60.5.405. PMC 5621069. PMID 28989916.

^ Coomarasamy A, Harb HM, Devall AJ, Cheed V, Roberts TE, Goranitis I,  et al. (June 2020). "Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT". Health Technology Assessment. 24 (33): 1–70. doi:10.3310/hta24330. PMC 7355406. PMID 32609084.

^ a b Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 1024–. ISBN 978-1-4757-2085-3.

^ a b Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 880–. ISBN 978-3-88763-075-1.

^ a b Marker RE, Krueger J (1940). "Sterols. CXII. Sapogenins. XLI. The Preparation of Trillin and its Conversion to Progesterone". J. Am. Chem. Soc. 62 (12): 3349–3350. doi:10.1021/ja01869a023.

^ Numazawa M, Nagaoka M, Kunitama Y (September 1986). "Regiospecific deoxygenation of the dihydroxyacetone moiety at C-17 of corticoid steroids with iodotrimethylsilane". Chemical & Pharmaceutical Bulletin. 34 (9): 3722–6. doi:10.1248/cpb.34.3722. PMID 3815593.

^ Heyl FW (1950). "Progesterone from 3-Acetoxybisnor-5-cholenaldehyde and 3-Ketobisnor-4-cholenaldehyde". Journal of the American Chemical Society. 72 (6): 2617–2619. doi:10.1021/ja01162a076.

^ Slomp G (1958). "Ozonolysis. II. 1 The Effect of Pyridine on the Ozonolysis of 4,22-Stigmastadien-3-one 2". Journal of the American Chemical Society. 80 (4): 915–921. doi:10.1021/ja01537a041.

^ Sundararaman P, Djerassi C (October 1977). "A convenient synthesis of progesterone from stigmasterol". The Journal of Organic Chemistry. 42 (22): 3633–4. doi:10.1021/jo00442a044. PMID 915584.

^ "Nova Transcripts: Forgotten Genius". PBS.org. February 6, 2007.

^ "Giants of the Past". lipidlibrary.aocs.org. Archived from the original on 2012-04-15.

^ a b c Johnson WS, Gravestock MB, McCarry BE (August 1971). "Acetylenic bond participation in biogenetic-like olefinic cyclizations. II. Synthesis of dl-progesterone". Journal of the American Chemical Society. 93 (17): 4332–4. doi:10.1021/ja00746a062. PMID 5131151.

^ Corner, George W.; Allen, Willard M. (1929-03-01). "Physiology of the corpus luteum". American Journal of Physiology. Legacy Content. 88 (2): 326–339. doi:10.1152/ajplegacy.1929.88.2.326. ISSN 0002-9513.

^ a b c Coutinho EM, Segal SJ (1999). Is Menstruation Obsolete?. Oxford University Press. pp. 31–. ISBN 978-0-19-513021-8.

^ Walker A (7 March 2008). The Menstrual Cycle. Routledge. pp. 49–. ISBN 978-1-134-71411-7.

^ Piosik R (2003). "Adolf Butenandt und sein Wirken an der Technischen Hochschule Danzig". Chemkon. 10 (3): 135–138. doi:10.1002/ckon.200390038.

^ Ginsburg B (6 December 2012). Premenstrual Syndrome: Ethical and Legal Implications in a Biomedical Perspective. Springer Science & Business Media. pp. 274–. ISBN 978-1-4684-5275-4.

^ Rolleston HD (1936). The Endocrine Organs in Health and Disease: With an Historical Review. Oxford University Press, H. Milford. p. 406.

^ Allen WM (October 1970). "Progesterone: how did the name originate?". Southern Medical Journal. 63 (10): 1151–5. doi:10.1097/00007611-197010000-00012. PMID 4922128. S2CID 35867375.

^ Refsal K (February 2009). "Interpretation of Serum Progesterone Results for Management of Breeding in Dogs" (PDF). Webcd.endo.ref.


External links[edit]
Progesterone MS Spectrum
Progesterone at the US National Library of Medicine Medical Subject Headings (MeSH)
Kimball JW (2007-05-27). "Progesterone". Kimball's Biology Pages. Archived from the original on 2008-06-18. Retrieved 2008-06-18.
.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}vteProgesteroneTopics
Progesterone (as a hormone)
Progesterone (as a medication)
Pharmacodynamics of progesterone
Pharmacokinetics of progesterone
Progesterone vaginal ring
Progestogen (as a hormone)
Progestogen (as a medication; including progestins)
Neurosteroid
Allopregnanolone
Pregnanolone

vteHormonesEndocrineglandsHypothalamic-pituitaryHypothalamus
GnRH
TRH
Dopamine
CRH
GHRH
Somatostatin (GHIH)
MCH
Posterior pituitary
Oxytocin
Vasopressin
Anterior pituitary
FSH
LH
TSH
Prolactin
POMC
CLIP
ACTH
MSH
Endorphins
Lipotropin
GH
Adrenal axis
Adrenal cortex
Aldosterone
Cortisol
Cortisone
DHEA
DHEA-S
Androstenedione
Adrenal medulla
Adrenaline
Norepinephrine
Thyroid
Thyroid hormones
T3
T4
Calcitonin
Thyroid axis
Parathyroid
PTH
Gonadal axisTestis
Testosterone
AMH
Inhibin
Ovary
Estradiol
Progesterone
Activin
Inhibin
Relaxin
GnSAF
Placenta
hCG
HPL
Estrogen
Progesterone
Pancreas
Glucagon
Insulin
Amylin
Somatostatin
Pancreatic polypeptide
Pineal gland
Melatonin
N,N-Dimethyltryptamine
5-Methoxy-N,N-dimethyltryptamine
OtherThymus
Thymosins
Thymosin α1
Beta thymosins
Thymopoietin
Thymulin
Digestive systemStomach
Gastrin
Ghrelin
Duodenum
CCK
Incretins
GIP
GLP-1
Secretin
Motilin
VIP
Ileum
Enteroglucagon
Peptide YY
Liver/other
Insulin-like growth factor
IGF-1
IGF-2
Adipose tissue
Leptin
Adiponectin
Resistin
Skeleton
Osteocalcin
Kidney
Renin
EPO
Calcitriol
Prostaglandin
Heart
Natriuretic peptide
ANP
BNP

vteEndogenous steroidsPrecursors
Cholesterol
22R-Hydroxycholesterol
20α,22R-Dihydroxycholesterol
Pregnenolone
11β-Hydroxypregnenolone
17α-Hydroxypregnenolone
21-Hydroxypregnenolone
17α,21-Dihydroxypregnenolone
11β,17α,21-Trihydroxypregnenolone
CorticosteroidsGlucocorticoids
3α,5α-Tetrahydrocorticosterone
5α-Dihydrocorticosterone
11-Deoxycorticosterone
11-Deoxycortisol
11-Ketoprogesterone
21-Deoxycortisol
21-Deoxycortisone
Corticosterone
Cortisol
Cortisone
17α-Hydroxypregnenolone
17α-Hydroxyprogesterone
Pregnenolone
Progesterone
Metabolites: 5α-Dihydrocortisol
3α,5α-Tetrahydrocortisol
Mineralocorticoids
5α-Dihydroaldosterone
11-Dehydrocorticosterone (11-oxocorticosterone, 17-deoxycortisone)
11-Deoxycortisol
11-Deoxycorticosterone
11β-Hydroxyprogesterone (21-deoxycorticosterone)
18-Hydroxy-11-deoxycorticosterone
18-Hydroxycorticosterone
18-Hydroxyprogesterone
Aldosterone
Corticosterone
Cortisol
Sex steroidsAndrogens
11-Ketodihydrotestosterone
11-Ketotestosterone
7β-Hydroxyepiandrosterone
11β-Hydroxyandrostenedione
Adrenosterone (11-ketoandrostenedione)
Androstenediol
Androstenedione
Androsterone
Dehydroandrosterone
DHEA
DHEA sulfate
Dihydrotestosterone
Epiandrosterone
Epitestosterone
16α-Hydroxyandrostenedione
16α-Hydroxy-DHEA
16α-Hydroxy-DHEA sulfate
Testosterone
Metabolites: 3α-Androstanediol
3α-Androstanediol glucuronide
3β-Androstanediol
5β-Dihydrotestosterone
3α-Etiocholanediol
3β-Etiocholanediol
Androstanetriols
Androstenediol sulfate
Androsterone glucuronide
Androsterone sulfate
Dihydrotestosterone glucuronide
Dihydrotestosterone sulfate
Etiocholanedione
Etiocholanolone
Etiocholanolone glucuronide
Epietiocholanolone
Testosterone glucuronide
Testosterone sulfate
Estrogens
Estranes: Estetrol
Estradiol
Estrone
Estriol
17α-Estradiol
16β-Epiestriol (16β-hydroxyestradiol)
17α-Epiestriol (16α-hydroxy-17α-estradiol)
16β,17α-Epiestriol (16β-hydroxy-17α-estradiol)
2-Hydroxyestradiol
2-Hydroxyestriol
2-Hydroxyestrone
4-Hydroxyestradiol
4-Hydroxyestriol
4-Hydroxyestrone
4-Methoxyestradiol
4-Methoxyestrone
16α-Hydroxyestrone
16β-Hydroxyestrone
16-Ketoestradiol
16-Ketoestrone
Others: 27-Hydroxycholesterol
3α-Androstanediol
3β-Androstanediol
4-Androstenedione
5-Androstenediol
DHEA
DHEA sulfate
7-Keto-DHEA
7α-Hydroxy-DHEA
16α-Hydroxy-DHEA
Metabolites: 2-Methoxyestradiol
2-Methoxyestrone
2-Methoxyestriol
4-Methoxyestriol
Estradiol disulfate
Estradiol glucuronide
Estradiol 3-glucuronide
Estradiol 3-glucuronide 17β-sulfate
Estradiol sulfate
Estradiol 17β-sulfate
Estrone glucuronide
Estrone sulfate
Estriol glucuronide
Estriol sulfate
Lipoidal estradiol (e.g., estradiol stearate, estradiol palmitate)
Progestogens
Progesterone
16α-Hydroxyprogesterone
17α-Hydroxyprogesterone
20α-Dihydroprogesterone
20β-Dihydroprogesterone
5α-Dihydroprogesterone
11-Deoxycorticosterone
5α-DHDOC
Metabolites: Allopregnanediol
Pregnanediol
Pregnanediol glucuronide
Pregnanetriol
Neurosteroids
Cholestanes: 24S-Hydroxycholesterol
Cholesterol
Pregnanes: 3α-Dihydroprogesterone
3β-Dihydroprogesterone
5α-Dihydrocorticosterone
5α-Dihydroprogesterone
5β-Dihydroprogesterone
Allopregnanolone
Corticosterone
DHC
DHDOC
11-Deoxycorticosterone
Epipregnanolone
Isopregnanolone
Pregnanolone
Pregnenolone
Pregnenolone sulfate
Progesterone
THB
THDOC
Androstanes: 3α-Androstanediol
3α-Androstenol
7-Keto-DHEA
7α-Hydroxy-DHEA
7β-Hydroxy-DHEA
7α-Hydroxyepiandrosterone
7β-Hydroxyepiandrosterone
Androsterone
DHEA
DHEA sulfate
Etiocholanolone
Pheromones: 3α-Androstenol
3β-Androstenol
Androstadienol
Androstadienone
Androstenone
Androsterone
Estratetraenol
Others
Vitamin D: 7-Dehydrocholesterol
Calcidiol/Calcifediol
Calcitriol
Cholecalciferol
Others: 7α-Hydroxycholesterol
11α-Hydroxyprogesterone
11β-Hydroxyprogesterone
Cholesterol sulfate

vteProgestogens and antiprogestogensProgestogens(and progestins)PR agonists
Progesterone derivatives: Progesterone
Quingestrone
Retroprogesterone derivatives: Dydrogesterone
Trengestone
17α-Hydroxyprogesterone (and closely related) derivatives: 17α-Hydroxylated: Acetomepregenol (mepregenol diacetate)
Algestone acetophenide (dihydroxyprogesterone acetophenide)
Anagestone acetate
Chlormadinone acetate
Chlormethenmadinone acetate
Cyproterone acetate
Delmadinone acetate
Flugestone acetate (flurogestone acetate)
Flumedroxone acetate
Hydroxyprogesterone acetate
Hydroxyprogesterone caproate
Hydroxyprogesterone heptanoate
Medroxyprogesterone acetate#
Megestrol acetate
Melengestrol acetate
Methenmadinone acetate
Osaterone acetate
Pentagestrone acetate
Proligestone; 17α-Methylated: Medrogestone; Others: Haloprogesterone
19-Norprogesterone derivatives: 17α-Hydroxylated: Gestonorone caproate (gestronol hexanoate)
Nomegestrol acetate
Norgestomet
Segesterone acetate (nestorone, elcometrine); 17α-Methylated: Demegestone
Promegestone
Trimegestone
Testosterone derivatives: Estranes: Danazol
Dimethisterone
Ethisterone
19-Nortestosterone derivatives: Estranes: Allylestrenol
Altrenogest
Dienogest
Etynodiol diacetate
Lynestrenol
Norethisterone (norethindrone)#
Norethisterone acetate
Norethisterone enanthate
Noretynodrel
Norgesterone
Norgestrienone
Normethandrone (methylestrenolone)
Norvinisterone
Oxendolone
Quingestanol acetate
Tibolone; Gonanes: Desogestrel
Etonogestrel
Gestodene
Gestrinone
Levonorgestrel#
Norelgestromin
Norgestimate
Norgestrel
Spirolactone derivatives: Drospirenone
Others: Anabolic–androgenic steroids (e.g., nandrolone and esters, trenbolone and esters, ethylestrenol, norethandrolone, others)
AntiprogestogensSPRMs
Telapristone§
Ulipristal acetate
PR antagonists
Aglepristone
Mifepristone

#WHO-EM
‡Withdrawn from market
Clinical trials:
†Phase III
§Never to phase III

See also
Progesterone receptor modulators
Androgens and antiandrogens
Estrogens and antiestrogens
List of progestogens
vteMineralocorticoids and antimineralocorticoids (H02)Mineralocorticoids
Desoxycortone (desoxycorticosterone)
Desoxycortone esters
Hydrocortisone (cortisol)
Hydrocortisone esters
Fludrocortisone
Fludrocortisone acetate
Methylprednisolone
Methylprednisolone esters
Prednisolone
Prednisolone esters
Prednisone
Prednisone esters
Antimineralocorticoids
Steroidal: Canrenoate potassium (potassium canrenoate)
Canrenone
Drospirenone
Dydrogesterone
Eplerenone
Gestodene
Medrogestone
Progesterone
Spironolactone
Trimegestone
Nonsteroidal: Amlodipine
Apararenone§
Benidipine
Esaxerenone†
Felodipine
Finerenone
Nifedipine
Nimodipine
Nitrendipine
Synthesis modifiers
Acetoxolone
Aminoglutethimide
Carbenoxolone
Enoxolone
Ketoconazole
Metyrapone
Mitotane
Trilostane

#WHO-EM
‡Withdrawn from market
Clinical trials:
†Phase III
§Never to phase III

See also
Mineralocorticoid receptor modulators
Glucocorticoids and antiglucocorticoids
List of corticosteroids
Biological activity
vteGABAA receptor positive modulatorsAlcohols
Brometone
Butanol
Chloralodol
Chlorobutanol (cloretone)
Ethanol (alcohol) (alcoholic drink)
Ethchlorvynol
Isobutanol
Isopropanol
Menthol
Methanol
Methylpentynol
Pentanol
Petrichloral
Propanol
tert-Butanol (2M2P)
tert-Pentanol (2M2B)
Tribromoethanol
Trichloroethanol
Triclofos
Trifluoroethanol
Barbiturates
(-)-DMBB
Allobarbital
Alphenal
Amobarbital
Aprobarbital
Barbexaclone
Barbital
Benzobarbital
Benzylbutylbarbiturate
Brallobarbital
Brophebarbital
Butabarbital/Secbutabarbital
Butalbital
Buthalital
Butobarbital
Butallylonal
Carbubarb
Crotylbarbital
Cyclobarbital
Cyclopentobarbital
Difebarbamate
Enallylpropymal
Ethallobarbital
Eterobarb
Febarbamate
Heptabarb
Heptobarbital
Hexethal
Hexobarbital
Metharbital
Methitural
Methohexital
Methylphenobarbital
Narcobarbital
Nealbarbital
Pentobarbital
Phenallymal
Phenobarbital
Phetharbital
Primidone
Probarbital
Propallylonal
Propylbarbital
Proxibarbital
Reposal
Secobarbital
Sigmodal
Spirobarbital
Talbutal
Tetrabamate
Tetrabarbital
Thialbarbital
Thiamylal
Thiobarbital
Thiobutabarbital
Thiopental
Thiotetrabarbital
Valofane
Vinbarbital
Vinylbital
Benzodiazepines
2-Oxoquazepam
3-Hydroxyphenazepam
Adinazolam
Alprazolam
Arfendazam
Avizafone
Bentazepam
Bretazenil
Bromazepam
Brotizolam
Camazepam
Carburazepam
Chlordiazepoxide
Ciclotizolam
Cinazepam
Cinolazepam
Clazolam
Climazolam
Clobazam
Clonazepam
Clonazolam
Cloniprazepam
Clorazepate
Clotiazepam
Cloxazolam
CP-1414S
Cyprazepam
Delorazepam
Demoxepam
Diazepam
Diclazepam
Doxefazepam
Elfazepam
Estazolam
Ethyl carfluzepate
Ethyl dirazepate
Ethyl loflazepate
Etizolam
EVT-201
FG-8205
Fletazepam
Flubromazepam
Flubromazolam
Fludiazepam
Flunitrazepam
Flunitrazolam
Flurazepam
Flutazolam
Flutemazepam
Flutoprazepam
Fosazepam
Gidazepam
Halazepam
Haloxazolam
Iclazepam
Imidazenil
Irazepine
Ketazolam
Lofendazam
Lopirazepam
Loprazolam
Lorazepam
Lormetazepam
Meclonazepam
Medazepam
Menitrazepam
Metaclazepam
Mexazolam
Midazolam
Motrazepam
N-Desalkylflurazepam
Nifoxipam
Nimetazepam
Nitrazepam
Nitrazepate
Nitrazolam
Nordazepam
Nortetrazepam
Oxazepam
Oxazolam
Phenazepam
Pinazepam
Pivoxazepam
Prazepam
Premazepam
Proflazepam
Pyrazolam
QH-II-66
Quazepam
Reclazepam
Remimazolam
Rilmazafone
Ripazepam
Ro48-6791
Ro48-8684
SH-053-R-CH3-2′F
Sulazepam
Temazepam
Tetrazepam
Tolufazepam
Triazolam
Triflubazam
Triflunordazepam (Ro5-2904)
Tuclazepam
Uldazepam
Zapizolam
Zolazepam
Zomebazam
Carbamates
Carisbamate
Carisoprodol
Clocental
Cyclarbamate
Difebarbamate
Emylcamate
Ethinamate
Febarbamate
Felbamate
Hexapropymate
Hydroxyphenamate
Lorbamate
Mebutamate
Meprobamate
Nisobamate
Pentabamate
Phenprobamate
Procymate
Styramate
Tetrabamate
Tybamate
Flavonoids
6-Methylapigenin
Ampelopsin (dihydromyricetin)
Apigenin
Baicalein
Baicalin
Catechin
EGC
EGCG
Hispidulin
Linarin
Luteolin
Rc-OMe
Skullcap constituents (e.g., baicalin)
Wogonin
Imidazoles
Etomidate
Metomidate
Propoxate
Kava constituents
10-Methoxyyangonin
11-Methoxyyangonin
11-Hydroxyyangonin
Desmethoxyyangonin
11-Methoxy-12-hydroxydehydrokavain
7,8-Dihydroyangonin
Kavain
5-Hydroxykavain
5,6-Dihydroyangonin
7,8-Dihydrokavain
5,6,7,8-Tetrahydroyangonin
5,6-Dehydromethysticin
Methysticin
7,8-Dihydromethysticin
Yangonin
Monoureides
Acecarbromal
Apronal (apronalide)
Bromisoval
Carbromal
Capuride
Ectylurea
Neuroactive steroids
Acebrochol
Allopregnanolone (brexanolone)
Alfadolone
Alfaxalone
3α-Androstanediol
Androstenol
Androsterone
Certain anabolic-androgenic steroids
Cholesterol
DHDOC
3α-DHP
5α-DHP
5β-DHP
DHT
Etiocholanolone
Ganaxolone
Hydroxydione
Minaxolone
ORG-20599
ORG-21465
P1-185
Pregnanolone (eltanolone)
Progesterone
Renanolone
SAGE-105
SAGE-324
SAGE-516
SAGE-689
SAGE-872
Testosterone
THDOC
Zuranolone
Nonbenzodiazepines
Cyclopyrrolones: Eszopiclone
Pagoclone
Pazinaclone
Suproclone
Suriclone
Zopiclone
Imidazopyridines: Alpidem
DS-1
Necopidem
Saripidem
Zolpidem
Pyrazolopyrimidines: Divaplon
Fasiplon
Indiplon
Lorediplon
Ocinaplon
Panadiplon
Taniplon
Zaleplon
Others: Adipiplon
CGS-8216
CGS-9896
CGS-13767
CGS-20625
CL-218,872
CP-615,003
CTP-354
ELB-139
GBLD-345
Imepitoin
JM-1232
L-838,417
Lirequinil (Ro41-3696)
NS-2664
NS-2710
NS-11394
Pipequaline
ROD-188
RWJ-51204
SB-205,384
SX-3228
TGSC01AA
TP-003
TPA-023
TP-13
U-89843A
U-90042
Viqualine
Y-23684
Phenols
Fospropofol
Propofol
Thymol
Piperidinediones
Glutethimide
Methyprylon
Piperidione
Pyrithyldione
Pyrazolopyridines
Cartazolate
Etazolate
ICI-190,622
Tracazolate
Quinazolinones
Afloqualone
Cloroqualone
Diproqualone
Etaqualone
Mebroqualone
Mecloqualone
Methaqualone
Methylmethaqualone
Nitromethaqualone
SL-164
Volatiles/gases
Acetone
Acetophenone
Acetylglycinamide chloral hydrate
Aliflurane
Benzene
Butane
Butylene
Centalun
Chloral
Chloral betaine
Chloral hydrate
Chloroform
Cryofluorane
Desflurane
Dichloralphenazone
Dichloromethane
Diethyl ether
Enflurane
Ethyl chloride
Ethylene
Fluroxene
Gasoline
Halopropane
Halothane
Isoflurane
Kerosine
Methoxyflurane
Methoxypropane
Nitric oxide
Nitrogen
Nitrous oxide
Norflurane
Paraldehyde
Propane
Propylene
Roflurane
Sevoflurane
Synthane
Teflurane
Toluene
Trichloroethane (methyl chloroform)
Trichloroethylene
Vinyl ether
Others/unsorted
3-Hydroxybutanal
α-EMTBL
AA-29504
Alogabat
Avermectins (e.g., ivermectin)
Bromide compounds (e.g., lithium bromide, potassium bromide, sodium bromide)
Carbamazepine
Chloralose
Chlormezanone
Clomethiazole
DEABL
Dihydroergolines (e.g., dihydroergocryptine, dihydroergosine, dihydroergotamine, ergoloid (dihydroergotoxine))
DS2
Efavirenz
Etazepine
Etifoxine
Fenamates (e.g., flufenamic acid, mefenamic acid, niflumic acid, tolfenamic acid)
Fluoxetine
Flupirtine
Hopantenic acid
Lanthanum
Lavender oil
Lignans (e.g., 4-O-methylhonokiol, honokiol, magnolol, obovatol)
Loreclezole
Menthyl isovalerate (validolum)
Monastrol
Niacin
Niacinamide
Org 25,435
Phenytoin
Propanidid
Retigabine (ezogabine)
Safranal
Seproxetine
Stiripentol
Sulfonylalkanes (e.g., sulfonmethane (sulfonal), tetronal, trional)
Terpenoids (e.g., borneol)
Topiramate
Valerian constituents (e.g., isovaleric acid, isovaleramide, valerenic acid, valerenol)
Unsorted benzodiazepine site positive modulators: α-Pinene
MRK-409 (MK-0343)
TCS-1105
TCS-1205
See also: Receptor/signaling modulators • GABA receptor modulators • GABA metabolism/transport modulators
vteGlucocorticoid receptor modulatorsGRAgonists
Cortisol-like and related (16-unsubstituted): 3α,5α-Tetrahydrocorticosterone
5α-Dihydrocorticosterone
9α-Fluorocortisone (alfluorone)
11-Dehydrocorticosterone (11-oxocorticosterone, 17-deoxycortisone)
11-Dehydrocorticosterone acetate
11-Deoxycorticosterone (desoxycortone, deoxycortone, desoxycorticosterone)
Desoxycortone esters
11-Deoxycortisol (cortodoxone, cortexolone)
Cortifen (cortiphen, kortifen)
Cortodoxone acetate
21-Deoxycortisol
Δ7-Prednisolone
Δ7-Prednisolone 21-acetate
Amebucort
Chloroprednisone
Chloroprednisone acetate
Cloprednol
Cloprednol acetate
Corticosterone
Corticosterone acetate
Corticosterone benzoate
Cortisol (hydrocortisone)
Benzodrocortisone (hydrocortisone benzoate)
Hydrocortamate (hydrocortisone diethylaminoacetate)
Hydrocortisone esters
Cortisone
Cortisone acetate
Deprodone
Deprodone propionate
Dichlorisone
Dichlorisone acetate
Dichlorisone diacetate
Difluprednate
Endrisone (endrysone)
Etiprednol
Etiprednol dicloacetate (etiprednol dichloroacetate)
Fludrocortisone (fludrocortone)
Fludrocortisone acetate
Fluorometholone
Fluorometholone acetate
Fluperolone
Fluperolone acetate
Fluprednisolone
Fluprednisolone esters
Halopredone
Halopredone acetate (halopredone diacetate)
Isoflupredone (9α-fluoroprednisolone)
Isoflupredone acetate
Loteprednol
Mazipredone (depersolone)
Medrysone
Methylprednisolone
Methylprednisolone esters
Prebediolone
Prebediolone acetate
Prednisolone
Prednazate
Prednazoline
Prednicarbate (prednisolone ethylcarbonate propionate)
Prednimustine
Prednisolamate (prednisolone diethylaminoacetate)
Prednisolone esters
Prednisone
Prednisone esters
Pregnenolone
Pregnenolone acetate
Pregnenolone succinate (pregnenolone hemisuccinate)
Resocortol
Tipredane
Tixocortol
Butixocort (tixocortol butyrate)
Butixocort propionate
Tixocortol pivalate
Methasones and related (16-substituted): 16α-Methyl-11-oxoprednisolone
Alclometasone
Alclometasone dipropionate
Amelometasone
Beclometasone (beclomethasone)
Beclometasone esters
Betamethasone (betametasone)
Betamethasone esters
Cortobenzolone (betamethasone salicylate)
Ciclometasone (ciclomethasone, cyclomethasone)
Clobetasol
Clobetasol propionate
Clobetasone
Clobetasone butyrate
Clocortolone
Clocortolone esters
Cloticasone
Cloticasone propionate
Cormetasone (cormethasone)
Cormetasone acetate
Descinolone
Desoximetasone (desoxymethasone)
Dexamethasone (dexametasone)
Dexamethasone esters
Diflorasone
Diflorasone diacetate
Diflucortolone
Diflucortolone pivalate
Diflucortolone valerate
Dimesone
Dimesone acetate
Doxibetasol (doxybetasol)
Fluclorolone
Flumetasone (flumethasone)
Flumetasone acetate
Flumetasone pivalate
Fluocinolone
Fluocortin
Fluocortin butyl (fluocortin butylate)
Fluocortolone
Fluocortolone esters
Fluprednidene (fluprednylidene)
Fluprednidene acetate
Fluticasone
Fluticasone furoate
Fluticasone propionate
Halocortolone
Halometasone
Icometasone
Icometasone enbutate (icometasone butyrate acetate)
Isoprednidene
Locicortolone (locicortone)
Locicortolone dicibate (locicortone dicibate)
Meclorisone
Meclorisone dibutyrate
Meprednisone (methylprednisone)
Meprednisone acetate
Meprednisone hydrogen succinate (methylprednisone hemisuccinate)
Mometasone
Mometasone furoate
Paramethasone
Paramethasone acetate
Paramethasone disodium phosphate
Paramethasone phosphate
Prednylidene
Prednylidene diethylaminoacetate
Rimexolone
Ticabesone
Ticabesone propionate
Timobesone
Timobesone acetate
Triamcinolone
Triamcinolone diacetate
Ulobetasol (halobetasol)
Ulobetasol propionate
Vamorolone
Cyclic ketals (16,17-cyclized): Acrocinonide (triamcinolone acroleinide)
Amcinafal (triamcinolone pentanonide)
Amcinafide (triamcinolone acetophenide)
Amcinonide (triamcinolone acetate cyclopentanonide)
Budesonide
Ciclesonide
Cicortonide
Deflazacort (azacort)
Descinolone acetonide
Desonide (hydroxyprednisolone acetonide)
Desonide disodium phosphate
Desonide pivalate
Dexbudesonide
Drocinonide
Drocinonide phosphate
Fluazacort
Fluclorolone acetonide (flucloronide)
Fludroxycortide (flurandrenolone, flurandrenolide)
Flumoxonide
Flunisolide
Flunisolide acetate
Fluocinolone acetonide
Ciprocinonide (fluocinolone acetonide cyclopropylcarboxylate)
Fluocinonide (fluocinolide, fluocinolone acetonide acetate)
Procinonide (fluocinolone acetonide propionate)
Formocortal
Halcinonide
Itrocinonide
Rofleponide
Rofleponide palmitate
Tralonide
Triamcinolone acetonide
Flupamesone (triamcinolone acetonide metembonate)
Triamcinolone acetonide esters
Triamcinolone aminobenzal benzamidoisobutyrate (TBI-PAB)
Triclonide
Others/atypical (other expanded steroid ring systems, homosteroids, and non-pregnane steroids): Cortisuzol
Cortivazol
Domoprednate
Naflocort
Nicocortonide
Nicocortonide acetate
Nivacortol (nivazol)
Oxisopred
RU-26988
RU-28362
Non-corticosteroids with some glucocorticoid activity: 15β-Hydroxycyproterone acetate
17α-Hydroxyprogesterone
Bromoketoprogesterone
Chlormadinone acetate
Cyproterone
Cyproterone acetate
Danazol
Delmadinone acetate
Desogestrel
DU-41165
Etonogestrel
Flugestone
Flugestone acetate (flurogestone acetate)
Fluoromedroxyprogesterone acetate
Fluoxymesterone
Gestodene
Medrogestone
Medroxyprogesterone acetate
Megestrol acetate
Metribolone
Norgestomet
Osaterone acetate
Progesterone
Promegestone
RU-2309
Quingestrone
Segesterone acetate (nestorone)
Tetrahydrogestrinone
Nonsteroidal glucocorticoids: AZD-5423
GSK-9027
Mixed(SEGRMs)
Dagrocorat
Fosdagrocorat
Mapracorat
Antagonists
7α-Hydroxy-DHEA
17α-Methylprogesterone
Aglepristone
Asoprisnil
Asoprisnil ecamate
C108297
C113176
CORT-108297
Cyproterone acetate
Dazucorilant
Exicorilant (CORT-125281)
Guggulsterone
Ketoconazole
Lilopristone
LLY-2707
Metapristone (RU-42633)
Miconazole
Mifepristone (RU-486)
Miricorilant (CORT-118335)
Onapristone
ORG-34116
ORG-34517 (SCH-900636)
ORG-34850
Pregnenolone 16α-carbonitrile
Relacorilant (CORT-125134)
RTI 3021–012
RTI 3021–022
Telapristone
Tibolone
Toripristone
Ulipristal acetate
Zavacorilant
Others
Antisense oligonucleotides: IONIS-GCCRRx (ISIS-426115)

See also
Receptor/signaling modulators
Glucocorticoids and antiglucocorticoids
Mineralocorticoid receptor modulators
List of corticosteroids

vteMineralocorticoid receptor modulatorsMRAgonists
11-Dehydrocorticosterone (11-oxocorticosterone, 17-deoxycortisone)
11-Dehydrocorticosterone acetate
11-Deoxycorticosterone (desoxycortone, deoxycortone, desoxycorticosterone)
Desoxycortone esters
11-Deoxycortisol (cortodoxone, cortexolone)
Cortifen (cortiphen, kortifen)
Cortodoxone acetate
11β-Hydroxyprogesterone
16α,18-Dihydroxy-11-deoxycorticosterone
17α-Hydroxyaldosterone
18-Hydroxy-11-deoxycorticosterone
19-Norprogesterone
Aldosterone
Corticosterone
Corticosterone acetate
Corticosterone benzoate
Cortisol (hydrocortisone)
Benzodrocortisone (hydrocortisone benzoate)
Hydrocortamate (hydrocortisone diethylaminoacetate)
Hydrocortisone esters
Cortisone
Cortisone acetate
Fludrocortisone (fludrocortone)
Fludrocortisone acetate
Mometasone
Mometasone furoate
Prednisolone
Prednazate
Prednazoline
Prednicarbate (prednisolone ethylcarbonate propionate)
Prednimustine
Prednisolamate (prednisolone diethylaminoacetate)
Prednisolone esters
Prednisone
Prednisone esters
Antagonists
Steroidal: 6β-Hydroxy-7α-thiomethylspironolactone
7α-Acetylthio-17α-hydroxyprogesterone
7α-Thiomethylspironolactone (SC-26519)
7α-Thioprogesterone (SC-8365)
7α-Thiospironolactone (SC-24813)
16α-Hydroxyprogesterone
17α-Hydroxyprogesterone (hydroxyprogesterone)
18-Deoxyaldosterone
18,19-Dinorprogesterone
Canrenoate potassium (potassium canrenoate)
Canrenoic acid (canrenoate)
Canrenone (canrenoate y-lactone)
Dicirenone
Dimethisterone
Drospirenone
Dydrogesterone
Eplerenone
Gestodene
Guggulsterone
Hydroxyprogesterone caproate
Medrogestone
Mespirenone
Metribolone
Mexrenoate potassium
Mexrenoic acid (mexrenoate)
Mexrenone
Oxprenoic acid (oxprenoate)
Oxprenoate potassium (RU-28318)
Pregnenolone
Progesterone
Prorenoate potassium
Prorenoic acid (prorenoate)
Prorenone
RO-14-9012
RU-26752
SC-5233 (spirolactone)
SC-8109
SC-11927 (CS-1)
SC-19886
SC-27169
Spirorenone
Spironolactone
Spiroxasone
Tibolone
Trimegestone
ZK-91587
ZK-97894
Nonsteroidal: Amlodipine
Apararenone
Benidipine
BR-4628
Esaxerenone
Felodipine
Finerenone
Miricorilant (CORT-118335)
Nifedipine
Nimodipine
Nitrendipine
Ocedurenone
PF-03882845
SM-368229

See also
Receptor/signaling modulators
Mineralocorticoids and antimineralocorticoids
Glucocorticoid receptor modulators
List of corticosteroids

vteNicotinic acetylcholine receptor modulatorsnAChRsAgonists(and PAMs)
5-HIAA
6-Chloronicotine
A-84,543
A-366,833
A-582,941
A-867,744
ABT-202
ABT-418
ABT-560
ABT-894
Acetylcholine
Altinicline
Anabasine
Anatabine
Anatoxin-a
AR-R17779
Bephenium hydroxynaphthoate
Butinoline
Butyrylcholine
Carbachol
Choline
Cotinine
Cytisine
Decamethonium
Desformylflustrabromine
Dianicline
Dimethylphenylpiperazinium
Epibatidine
Epiboxidine
Ethanol (alcohol)
Ethoxysebacylcholine
EVP-4473
EVP-6124
Galantamine
GTS-21
Ispronicline
Ivermectin
JNJ-39393406
Levamisole
Lobeline
MEM-63,908 (RG-3487)
Morantel
Nicotine (tobacco)
NS-1738
PHA-543,613
PHA-709,829
PNU-120,596
PNU-282,987
Pozanicline
Pyrantel
Rivanicline
RJR-2429
Sazetidine A
SB-206553
Sebacylcholine
SIB-1508Y
SIB-1553A
SSR-180,711
Suberyldicholine
Suxamethonium (succinylcholine)
Suxethonium (succinyldicholine)
TC-1698
TC-1734
TC-1827
TC-2216
TC-5214
TC-5619
TC-6683
Tebanicline
Tribendimidine
Tropisetron
UB-165
Varenicline
WAY-317,538
XY-4083
Antagonists(and NAMs)
18-MAC
18-MC
α-Neurotoxins (e.g., α-bungarotoxin, α-cobratoxin, α-conotoxin, many others)
ABT-126
Alcuronium
Allopregnanolone
Amantadine
Anatruxonium
AQW051
Atracurium
Barbiturates (e.g., pentobarbital, sodium thiopental)
BNC-210
Bungarotoxins (e.g., α-bungarotoxin, κ-bungarotoxin)
Bupropion
BW284C51
BW-A444
Candocuronium iodide (chandonium iodide)
Chlorisondamine
Cisatracurium
Coclaurine
Coronaridine
Curare
Cyclopropane
Dacuronium bromide
Decamethonium
Dehydronorketamine
Desflurane
Dextromethorphan
Dextropropoxyphene
Dextrorphan
Diadonium
DHβE
Dihydrochandonium
Dimethyltubocurarine (metocurine)
Dioscorine
Dipyrandium
Dizocilpine (MK-801)
Doxacurium
Encenicline
Enflurane
Erythravine
Esketamine
Fazadinium
Gallamine
Gantacurium chloride
Halothane
Hexafluronium
Hexamethonium (benzohexonium)
Hydroxybupropion
Hydroxynorketamine
Ibogaine
Isoflurane
Ketamine
Kynurenic acid
Laudanosine
Laudexium (laudolissin)
Levacetylmethadol
Levomethadone
Malouetine
ME-18-MC
Mecamylamine
Memantine
Methadone
Methorphan (racemethorphan)
Methyllycaconitine
Metocurine
Mivacurium
Morphanol (racemorphan)
Neramexane
Nitrous oxide
Norketamine
Pancuronium bromide
Pempidine
Pentamine
Pentolinium
Phencyclidine
Pipecuronium bromide
Progesterone
Promegestone
Radafaxine
Rapacuronium bromide
Reboxetine
Rocuronium bromide
Sevoflurane
Stercuronium iodide
Surugatoxin
Thiocolchicoside
Toxiferine
Tramadol
Trimetaphan camsilate (trimethaphan camsylate)
Tropeinium
Tubocurarine
Vanoxerine
Vecuronium bromide
Xenon
Precursors(and prodrugs)
Acetyl-coA
Adafenoxate
Choline (lecithin)
Citicoline
Cyprodenate
Dimethylethanolamine
Glycerophosphocholine
Meclofenoxate (centrophenoxine)
Phosphatidylcholine
Phosphatidylethanolamine
Phosphorylcholine
Pirisudanol
See also: Receptor/signaling modulators • Muscarinic acetylcholine receptor modulators • Acetylcholine metabolism/transport modulators
vteProgesterone receptor modulatorsPRAgonists
Progesterone derivatives: 3β-Dihydroprogesterone
5α-Dihydroprogesterone
6α-Methylprogesterone
9α-Bromo-11-ketoprogesterone
11-Dehydroprogesterone
11-Deoxycorticosterone
16α-Hydroxyprogesterone
17α-Methyl-11-deoxycorticosterone acetate
20α-Dihydroprogesterone
20β-Dihydroprogesterone
Dimepregnen
Diosgenin
P1-185
Progesterone
Progesterone 3-acetyl enol ether
Quingestrone
Retroprogesterone derivatives: 20α-Dihydrodydrogesterone
20α-Dihydrotrengestone
DU-41164
DU-41165
Dydrogesterone
Retroprogesterone
Ro 6-3129
Trengestone
17α-Substituted progesterone derivatives: 6α-Methyl-17α-bromoprogesterone
15β-Hydroxycyproterone acetate
16-Methylene-17α-hydroxyprogesterone acetate
17α-Bromoprogesterone
17α-Hydroxyprogesterone (hydroxyprogesterone)
17α-Methylprogesterone
Acetomepregenol (mepregenol diacetate)
Algestone
Algestone acetonide
Algestone acetophenide
Anagestone
Anagestone acetate
Bromethenmadinone
Bromethenmadinone acetate
Butagest (buterol)
Chlormadinone
Chlormadinone acetate
Chlormadinone caproate
Chlormethenmadinone
Chlormethenmadinone acetate
Cismadinone
Cismadinone acetate
Clogestone
Clogestone acetate
Clomegestone
Clomegestone acetate
Cymegesolate
Cyproterone acetate
Delmadinone
Delmadinone acetate
Edogestrone
Flugestone
Flugestone acetate
Fluorometholone
Fluorometholone acetate
Flumedroxone
Flumedroxone acetate
Fluoromedroxyprogesterone acetate
Gestaclone
Gestobutanoyl
Haloprogesterone
Hydromadinone
Hydromadinone acetate
Hydroxyprogesterone acetate
Hydroxyprogesterone caproate (hydroxyprogesterone hexanoate)
Hydroxyprogesterone heptanoate (hydroxyprogesterone enanthate)
Hydroxyprogesterone heptanoate benzilic acid hydrazone
Mecigestone (pentarane B)
Medrogestone
Medroxyprogesterone
Medroxyprogesterone acetate
Medroxyprogesterone caproate
Megestrol
Megestrol acetate
Megestrol caproate
Melengestrol
Melengestrol acetate
Methenmadinone
Methenmadinone acetate
Methenmadinone caproate
Mometasone
Mometasone furoate
Osaterone
Osaterone acetate
Pentagestrone
Pentagestrone acetate
Pentarane A
Proligestone
Triamcinolone acetonide
19-Norprogesterone derivatives: 17α-Methyl-19-norprogesterone
18-Methylsegesterone acetate
19-Norprogesterone
Amadinone
Amadinone acetate
Demegestone
Fluoro ethyl norprogesterone
Fluoro furanyl norprogesterone
Gestadienol
Gestadienol acetate
Gestonorone acetate (gestronol acetate)
Gestonorone caproate (gestronol hexanoate)
Gestronol (gestonorone)
Nomegestrol
Nomegestrol acetate
Norgestomet
ORG-2058
Oxogestone
Oxogestone phenpropionate (xinogestone)
Promegestone
Segesterone
Segesterone acetate (nestorone)
Trimegestone
Testosterone derivatives: Progestins: 6,6-Difluoronorethisterone
6,6-Difluoronorethisterone acetate
17α-Allyl-19-nortestosterone
Allylestrenol
Altrenogest
Chloroethynylnorgestrel
Cingestol
Danazol
Desogestrel
Dienogest
Ethinylandrostenediol
Ethandrostate
Ethisterone
Ethynerone
Etonogestrel
Etynodiol
Etynodiol diacetate
Gestodene
Gestrinone
Levonorgestrel
Levonorgestrel esters (e.g., levonorgestrel butanoate)
Lynestrenol
Lynestrenol phenylpropionate
Metynodiol
Metynodiol diacetate
Norelgestromin
Norethisterone (norethindrone)
Norethisterone esters (e.g., norethisterone acetate, norethisterone enanthate)
Noretynodrel
Norgesterone
Norgestimate
Norgestrel
Norgestrienone
Norvinisterone
Oxendolone
Quingestanol
Quingestanol acetate
Tibolone
Tigestol
Tosagestin; Anabolic–androgenic steroids: 11β-Methyl-19-nortestosterone
11β-Methyl-19-nortestosterone dodecylcarbonate
19-Nor-5-androstenediol
19-Nor-5-androstenedione
19-Nordehydroepiandrosterone
Bolandiol
Bolandiol dipropionate
Bolandione
Dimethisterone
Dienedione
Dienolone
Dimethandrolone
Dimethandrolone buciclate
Dimethandrolone dodecylcarbonate
Dimethandrolone undecanoate
Dimethyldienolone
Dimethyltrienolone
Ethyldienolone
Ethylestrenol (ethylnandrol)
Methyldienolone
Metribolone (R-1881)
Methoxydienone (methoxygonadiene)
Mibolerone
Nandrolone
Nandrolone esters (e.g., nandrolone decanoate, nandrolone phenylpropionate)
Norethandrolone
Normethandrone (methylestrenolone, normethandrolone, normethisterone)
RU-2309
Tetrahydrogestrinone
Trenbolone (trienolone)
Trenbolone esters (e.g., trenbolone acetate, trenbolone enanthate)
Trendione
Trestolone
Trestolone acetate
Spirolactone derivatives: Canrenoic acid
Canrenone
Drospirenone
Mespirenone
Potassium canrenoate
Prorenone
SC-5233 (spirolactone)
SC-8109
Spironolactone
Spirorenone
Nonsteroidal: 3,8-Dihydrodiligustilide
LG-2527
LG-100128
Riligustilide
RWJ-26819
RWJ-49853
RWJ-60130
Tanaproget
ZM-182345
Unknown: ORG-47241
ORG-201745
Mixed(SPRMs)
Steroidal: Dihydroethisterone
5α-Dihydrolevonorgestrel
5α-Dihydronorethisterone
Asoprisnil
Asoprisnil ecamate
Guggulsterone
J1042
LG-120838
Metapristone (RU-42633)
Mifepristone (RU-486)
ORF-9371
ORF-9326
ORG-31710
ORG-33628
RMI-12936
Telapristone
Ulipristal acetate
Vilaprisan
ZK-137316
Nonsteroidal: Apigenin
Kaempferol
LG-120920
Naringenin
PRA-910
Syringic acid
Antagonists
Steroidal: Aglepristone
Lilopristone
Lonaprisan
Onapristone
ORG-31710
ORG-31806
ORG-33628
RTI 3021–022
Toripristone
Zanoterone
Nonsteroidal: Darolutamide
LG-001447
LG-100127
LG-100128
LG-120830
LG-121046
Valproic acid
ZM-150271
ZM-172406
mPR(PAQR)Agonists
5α-Dihydroprogesterone
5β-Dihydroprogesterone
11-Deoxycortisone (21-hydroxyprogesterone)
11-Deoxycortisol (17α,21-dihydroxyprogesterone)
17α-Hydroxyprogesterone
Allopregnanolone
Mifepristone
Pregnenolone
Progesterone
Antagonists
Mifepristone

See also
Receptor/signaling modulators
Progestogens and antiprogestogens
Androgen receptor modulators
Estrogen receptor modulators
List of progestogens

vteSigma receptor modulatorsσ1
Agonists: 3-PPP
4-PPBP
5-MeO-DMT
Alazocine (SKF-10047)
Amantadine
Arketamine
BD-737
BD-1052
Blarcamesine
Captodiame
Citalopram
CGRP
Cloperastine
Cocaine
Cutamesine (SA-4503)
Cyclazocine
Dehydroepiandrosterone (DHEA) (prasterone)
Dehydroepiandrosterone sulfate (DHEA-S) (prasterone sulfate)
Dextrallorphan
Dextromethorphan (DXM)
Dextrorphan (DXO)
Dimemorfan
Dimethyltryptamine (DMT)
Ditolylguanidine (DTG)
Donepezil
Eliprodil
Escitalopram
Fabomotizole (afobazole)
Fluoxetine
Fluvoxamine
Ifenprodil
Igmesine (JO-1784)
IPAB
Ketamine
L-687384
MDMA (midomafetamine)
Memantine
Methamphetamine
Methoxetamine
Methylphenidate
Nepinalone
Neuropeptide Y
Noscapine
OPC-14523
Opipramol
Pentazocine
Pentoxyverine (carbetapentane)
PRE-084
Pregnenolone
Pregnenolone sulfate
Pridopidine
Racemethorphan (methorphan)
Racemorphan (morphanol)
UMB-23
UMB-82
Antagonists: 3-PPP
AC-927
BD-1008
BD-1031
BD-1047
BD-1060
BD-1063
BD-1067
BMY-14802 (BMS-181100)
CM-156
Dup-734
E-5842
E-52862 (S1RA)
Haloperidol
LR-132
LR-172
MS-377
NE-100
NPC-16377
Panamesine (EMD-57455)
PD-144418
Pentazocine
Progesterone
Rimcazole (BW-234U)
Sertraline
SR-31742A
Allosteric modulators: Phenytoin; Positive: Methylphenylpiracetam
SOMCL-668
Unknown/unsorted: 3-Methoxydextrallorphan
3-MeO-PCP
4C-T-2
4-IBP
4-IPBS
4-MeO-PCP
5-MeO-DALT
5-MeO-DiPT
Amitriptyline
Azidopamil
Chlorpromazine
Clemastine
Clomipramine
Clorgiline
D-Deprenyl
DiPT
DPT
Ibogaine
Imipramine
KCR-12-83.1
Nemonapride
Noribogaine
RHL-033
RS-67,333
RTI-55
Saffron
Safinamide
Selegiline
Spipethiane
Trifluoperazine
W-18
YKP10A
σ2
Agonists: 3-PPP
Arketamine
BD-1047
BD1063
Ditolylguanidine (DTG)
DKR-1005
DKR-1051
Haloperidol
Ifenprodil
Ketamine
MDMA (midomafetamine)
Methamphetamine
OPC-14523
Opipramol
PB-28
Phencyclidine
Siramesine (Lu 28-179)
UKH-1114
Antagonists: AC-927
BD-1008
BD-1067
CM-156
CT-1812
LR-172
MIN-101
Panamesine (EMD-57455)
SAS-0132
Unknown/unsorted: 3-Methoxydextrallorphan
3-MeO-PCE
4-MeO-PCP
5-MeO-DALT
5-MeO-DiPT
Clemastine
DiPT
DPT
Ibogaine
Nemonapride
Nepinalone
Noribogaine
Pentazocine
RS-67,333
Safinamide
TMA
UMB-23
UMB-82
W-18
Unsorted
Agonists: Berberine
Ethylketazocine
Fourphit
Metaphit
Naluzotan
Tapentadol
Tenocyclidine
Antagonists: AHD1
AZ66
Lamotrigine
Naloxone
SM-21
UMB-100
UMB-101
UMB-103
UMB-116
YZ-011
YZ-069
YZ-185
Allosteric modulators: SKF-83959
Unknown/unsorted: 18-Methoxycoronaridine
BMY-13980
Butaclamol
Caramiphen
Carvotroline
Chlorphenamine (chlorpheniramine)
Chlorpromazine
Cinnarizine
Cinuperone
Clocapramine
Dezocine
EMD-59983
Hypericin (St. John's wort)
Fluphenazine
Gevotroline (WY-47384)
Mepyramine (pyrilamine)
Molindone
Perphenazine
Pimozide
Proadifen
Promethazine
Propranolol
Quinidine
Remoxipride
SL 82.0715
SR-31747A
Tiospirone (BMY-13859)
Venlafaxine
See also: Receptor/signaling modulators
vteXenobiotic-sensing receptor modulatorsCAR
Agonists: 6,7-Dimethylesculetin
Amiodarone
Artemisinin
Benfuracarb
Carbamazepine
Carvedilol
Chlorpromazine
Chrysin
CITCO
Clotrimazole
Cyclophosphamide
Cypermethrin
DHEA (prasterone)
Efavirenz
Ellagic acid
Griseofulvin
Methoxychlor
Mifepristone
Nefazodone
Nevirapine
Nicardipine
Octicizer
Permethrin
Phenobarbital
Phenytoin
Pregnanedione (5β-dihydroprogesterone)
Reserpine
TCPOBOP
Telmisartan
Tolnaftate
Troglitazone
Valproic acid
Antagonists: 3,17β-Estradiol
3α-Androstanol
3α-Androstenol
3β-Androstanol
17-Androstanol
AITC
Ethinylestradiol
Meclizine
Nigramide J
Okadaic acid
PK-11195
S-07662
T-0901317
PXR
Agonists: 17α-Hydroxypregnenolone
17α-Hydroxyprogesterone
Δ4-Androstenedione
Δ5-Androstenediol
Δ5-Androstenedione
AA-861
Allopregnanediol
Allopregnanedione (5α-dihydroprogesterone)
Allopregnanolone (brexanolone)
Alpha-Lipoic acid
Ambrisentan
AMI-193
Amlodipine besylate
Antimycotics
Artemisinin
Aurothioglucose
Bile acids
Bithionol
Bosentan
Bumecaine
Cafestol
Cephaloridine
Cephradine
Chlorpromazine
Ciglitazone
Clindamycin
Clofenvinfos
Chloroxine
Clotrimazole
Colforsin
Corticosterone
Cyclophosphamide
Cyproterone acetate
Demecolcine
Dexamethasone
DHEA (prasterone)
DHEA-S (prasterone sulfate)
Dibunate sodium
Diclazuril
Dicloxacillin
Dimercaprol
Dinaline
Docetaxel
Docusate calcium
Dodecylbenzenesulfonic acid
Dronabinol
Droxidopa
Eburnamonine
Ecopipam
Enzacamene
Epothilone B
Erythromycin
Famprofazone
Febantel
Felodipine
Fenbendazole
Fentanyl
Flucloxacillin
Fluorometholone
Griseofulvin
Guggulsterone
Haloprogin
Hetacillin potassium
Hyperforin
Hypericum perforatum (St John's wort)
Indinavir sulfate
Lasalocid sodium
Levothyroxine
Linolenic acid
LOE-908
Loratadine
Lovastatin
Meclizine
Metacycline
Methylprednisolone
Metyrapone
Mevastatin
Mifepristone
Nafcillin
Nicardipine
Nicotine
Nifedipine
Nilvadipine
Nisoldipine
Norelgestromin
Omeprazole
Orlistat
Oxatomide
Paclitaxel
Phenobarbital
Piperine
Plicamycin
Prednisolone
Pregnanediol
Pregnanedione (5β-dihydroprogesterone)
Pregnanolone
Pregnenolone
Pregnenolone 16α-carbonitrile
Proadifen
Progesterone
Quingestrone
Reserpine
Reverse triiodothyronine
Rifampicin
Rifaximin
Rimexolone
Riodipine
Ritonavir
Simvastatin
Sirolimus
Spironolactone
Spiroxatrine
SR-12813
Suberoylanilide
Sulfisoxazole
Suramin
Tacrolimus
Tenylidone
Terconazole
Testosterone isocaproate
Tetracycline
Thiamylal sodium
Thiothixene
Thonzonium bromide
Tianeptine
Troglitazone
Troleandomycin
Tropanyl 3,5-dimethulbenzoate
Zafirlukast
Zeranol
Antagonists: Ketoconazole
Sesamin

See also
Receptor/signaling modulators






